UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

Date: March 6, 2023

 

UBS Group AG

Commission File Number: 1-36764

 

UBS AG

Commission File Number: 1-15060

 

 

(Registrants' Name)

 

Bahnhofstrasse 45, Zurich, Switzerland and
Aeschenvorstadt 1, Basel, Switzerland

(Address of principal executive offices)

 

Indicate by check mark whether the registrants file or will file annual reports under cover of Form 20‑F or Form 40-F.

 

Form 20-F                         Form 40-F 

 


       

This Form 6-K consists of the UBS AG audited standalone financial statements for the year ended 31 December 2022, as well as the consent of Ernst & Young Ltd. with respect thereto, which appear immediately following this page.

 

 


     

UBS AG

  Standalone financial statements and regulatory

  Information for the year ended 31 December 2022

 

A couple sitting on a dock

Description automatically generated with medium confidence

 



     

UBS AG standalone financial statements
(audited)

Income statement

 

 

 

 

 

 

 

 

 

 

 

 

USD m

 

CHF m

 

 

 

 

For the year ended

 

For the year ended

 

 

Note

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Interest and discount income1

 

 

 

7,133

4,091

 

6,821

3,745

Interest and dividend income from trading portfolio1

 

 

 

2,199

2,572

 

2,097

2,360

Interest and dividend income from financial investments

 

 

 

359

115

 

344

105

Interest expense2

 

 

 

(9,197)

(5,128)

 

(8,799)

(4,704)

Gross interest income

 

 

 

495

1,649

 

463

1,506

Credit loss (expense) / release

 

13

 

18

78

 

17

72

Net interest income

 

 

 

513

1,727

 

480

1,578

Fee and commission income from securities and investment business and other fee and commission income

 

 

 

2,756

3,703

 

2,618

3,390

Credit-related fees and commissions

 

 

 

99

109

 

95

100

Fee and commission expense

 

 

 

(684)

(810)

 

(651)

(741)

Net fee and commission income

 

 

 

2,171

3,002

 

2,062

2,749

Net trading income

 

 3  

 

5,796

3,623

 

5,512

3,301

Net income from disposal of financial investments

 

 

 

(110)

56

 

(106)

52

Dividend income from investments in subsidiaries and other participations

 

4

 

6,465

6,401

 

6,183

5,882

Income from real estate holdings

 

 

 

394

480

 

375

439

Sundry ordinary income

 

5

 

1,467

1,342

 

1,397

1,229

Sundry ordinary expenses

 

5

 

(937)

(338)

 

(888)

(308)

Other income from ordinary activities

 

 

 

7,279

7,940

 

6,962

7,295

Total operating income

 

 

 

15,759

16,293

 

15,015

14,923

Personnel expenses

 

6

 

3,109

3,221

 

2,960

2,943

General and administrative expenses

 

7

 

3,543

3,625

 

3,375

3,317

Subtotal operating expenses

 

 

 

6,653

6,846

 

6,334

6,260

Impairment of investments in subsidiaries and other participations

 

4

 

1,056

1,187

 

1,014

1,090

Depreciation, amortization and impairment of property, equipment, software and intangible assets

 

 

 

743

816

 

708

747

Changes in provisions for litigation, regulatory and similar matters, and other provisions

 

8

 

54

862

 

50

787

Total operating expenses

 

 

 

8,505

9,712

 

8,106

8,885

Operating profit

 

 

 

7,253

6,581

 

6,909

6,037

Extraordinary income

 

9

 

201

282

 

191

262

Extraordinary expenses

 

9

 

2

1

 

2

1

Tax expense / (benefit)

 

10

 

295

315

 

281

286

Net profit / (loss)

 

 

 

7,157

6,548

 

6,817

6,013

1 Interest income includes negative interest income of approximately USD 0.4bn (CHF 0.4bn) for the year ended 31 December 2022 (approximately USD 0.5bn (CHF 0.4bn) for the year ended 31 December 2021).    2 Includes negative interest expense on financial liabilities of approximately USD 0.4bn (CHF 0.4bn) for the year ended 31 December 2022 (approximately USD 0.5bn (CHF 0.4bn) for the year ended 31 December 2021).

 

UBS AG standalone financial statements (audited)                                                                                                                                                         1 


     

Balance sheet

 

 

 

 

 

 

 

 

 

 

USD m

 

CHF m

 

 

Note

 

31.12.22

31.12.21

 

31.12.22

31.12.21

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

Cash and balances at central banks

 

13

 

48,344

53,760

 

44,684

49,012

Due from banks

 

13, 24

 

31,450

33,330

 

29,069

30,386

Receivables from securities financing transactions

 

11, 13, 24

 

58,141

56,336

 

53,739

51,360

Due from customers

 

12, 13, 24

 

105,552

121,812

 

97,561

111,052

Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity1

 

12, 13, 24

 

27,678

27,530

 

25,582

25,098

Mortgage loans

 

12, 13

 

5,039

5,492

 

4,657

5,007

Trading portfolio assets

 

14

 

98,566

119,795

 

91,104

109,213

Derivative financial instruments

 

15

 

14,701

11,921

 

13,588

10,868

Financial investments

 

16

 

43,746

19,482

 

40,434

17,761

Accrued income and prepaid expenses

 

13

 

1,872

1,213

 

1,730

1,106

Investments in subsidiaries and other participations

 

4

 

51,029

50,671

 

47,165

46,195

Property, equipment and software

 

 

 

5,134

5,580

 

4,745

5,087

Other assets

 

12, 13, 17

 

13,516

2,927

 

12,491

2,667

Total assets

 

 

 

504,767

509,851

 

466,550

464,814

of which: subordinated assets

 

 

 

18,748

18,751

 

17,329

17,095

of which: subject to mandatory conversion and / or debt waiver

 

 

 

18,042

17,813

 

16,676

16,239

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Due to banks

 

24

 

47,329

40,293

 

43,745

36,734

Payables from securities financing transactions

 

11, 24

 

23,497

23,046

 

21,718

21,010

Due to customers

 

24

 

138,941

141,119

 

128,421

128,654

Funding received from UBS Group AG measured at amortized cost

 

21, 24

 

61,202

57,078

 

56,568

52,036

Trading portfolio liabilities

 

14

 

25,058

25,711

 

23,160

23,440

Derivative financial instruments

 

15

 

17,429

14,128

 

16,109

12,880

Financial liabilities designated at fair value

 

14, 20

 

70,603

73,081

 

65,258

66,625

of which: funding received from UBS Group AG

 

20, 21, 24

 

1,959

2,137

 

1,811

1,948

Bonds issued

 

21

 

56,148

73,631

 

51,897

67,127

Accrued expenses and deferred income

 

 

 

3,592

2,919

 

3,320

2,661

Other liabilities

 

17

 

1,582

2,305

 

1,462

2,100

Provisions

 

13

 

2,026

2,136

 

1,872

1,947

Total liabilities

 

 

 

447,406

455,446

 

413,532

415,215

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

Share capital

 

22

 

393

393

 

386

386

General reserve

 

 

 

36,326

36,326

 

35,649

35,649

of which: statutory capital reserve

 

 

 

36,326

36,326

 

35,649

35,649

of which: capital contribution reserve2

 

 

 

36,326

36,326

 

35,649

35,649

Voluntary earnings reserve

 

 

 

13,485

11,138

 

10,167

7,552

Net profit / (loss) for the period

 

 

 

7,157

6,548

 

6,817

6,013

Total equity

 

 

 

57,361

54,405

 

53,018

49,599

Total liabilities and equity

 

 

 

504,767

509,851

 

466,550

464,814

of which: subordinated liabilities

 

 

 

66,872

65,219

 

61,809

59,459

of which: subject to mandatory conversion and / or debt waiver

 

 

 

66,314

64,654

 

61,293

58,943

1 Represents the Swiss GAAP carrying amount of instruments qualifying as total loss-absorbing capital at the level of the respective subsidiaries.    2 The Swiss Federal Tax Administration’s current position is that, of the CHF 35.6bn capital contribution reserve available as of 31 December 2022, an amount limited to CHF 20.5bn is available from which dividends may be paid without a Swiss withholding tax deduction.   

 

UBS AG standalone financial statements (audited)                                                                                                                                                         2 


     

 

Balance sheet (continued)

 

 

 

 

 

 

 

 

USD m

 

CHF m

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

 

 

 

 

 

 

 

Off-balance sheet items

 

 

 

 

 

 

Contingent liabilities, gross

 

20,359

19,046

 

18,818

17,364

Sub-participations

 

(1,069)

(1,093)

 

(988)

(997)

Contingent liabilities, net

 

19,290

17,953

 

17,830

16,367

of which: guarantees to third parties related to subsidiaries

 

6,156

7,825

 

5,690

7,133

Irrevocable loan commitments, gross

 

16,272

17,394

 

15,041

15,858

Sub-participations

 

0

0

 

0

0

Irrevocable loan commitments, net

 

16,272

17,394

 

15,041

15,858

Forward starting transactions1

 

54,321

41,719

 

50,208

38,034

of which: reverse repurchase agreements

 

27,343

24,559

 

25,273

22,390

of which: repurchase agreements

 

26,978

17,160

 

24,936

15,644

Liabilities for calls on shares and other equity instruments

 

5

5

 

4

4

1 Cash to be paid in the future by either UBS AG or the counterparty.

Off-balance sheet items

Contingent liabilities include indemnities and guarantees issued by UBS AG for the benefit of subsidiaries and creditors of subsidiaries.

Where the indemnity amount issued by UBS AG is not specifically defined, the indemnity relates to the solvency or minimum capitalization of a subsidiary, and therefore no amount is included in the table above.

Joint and several liability – value-added tax

UBS AG is jointly and severally liable for the combined value-added tax (VAT) liability of UBS entities that belong to the VAT group of UBS in Switzerland. This contingent liability is not included in the table above.

Guarantees – UBS Europe SE

Following the combined UK business transfer and cross-border merger of UBS Limited into UBS Europe SE in March 2019, UBS AG issued a guarantee for the benefit of counterparties of UBS Europe SE’s investment banking business, covering transactions subject to master netting agreements.

A similar guarantee that UBS AG issued in 2003 for the benefit of each counterparty of UBS Limited also continues to be effective. This guarantee covers transactions in accordance with and contemplated under any agreement entered into by UBS Limited prior to the merger into UBS Europe SE, to the extent that such an agreement has not been amended by UBS Europe SE thereafter.

Under both guarantees, UBS AG promises to pay to the beneficiary counterparties any unpaid liabilities covered under the terms of the guarantees on demand. These guarantees are included as contingent liabilities in the off-balance sheet items table above.

Indemnities – UBS Europe SE

In connection with the establishing of UBS Europe SE in 2016, UBS AG entered into agreements with UBS Europe SE under which UBS AG would provide UBS Europe SE with limited indemnification of payment obligations that may arise from certain litigation, regulatory and similar matters.

As of 31 December 2022, the amount of such potential payment obligations could not be reliably estimated and the likelihood of an outflow is not considered to be probable or the probability of an outflow was assessed to be remote; therefore, the table above does not include any amount related to this limited indemnification.

In addition, in accordance with the bylaws of the Deposit Protection Fund of the Association of German Banks, UBS AG issued an indemnity in favor of this fund on behalf of UBS Europe SE. The probability of an outflow was assessed to be remote, and as a result, the table above does not include any exposure arising under this indemnity.

 

UBS AG standalone financial statements (audited)                                                                                                                                                         3 


     

 

Statement of changes in equity

 

 

 

 

 

USD m

Share capital

Statutory capital reserve

Voluntary earnings

reserve and

profit / (loss)

carried forward

Net profit / (loss)

for the period

Total equity

 

 

 

 

 

 

Balance as of 1 January 2022

393

36,326

11,138

6,548

54,405

Dividend distribution

 

 

(4,200)

 

(4,200)

Net profit / (loss) appropriation

 

 

6,548

(6,548)

0

Net profit / (loss) for the period

 

 

 

7,157

7,157

Balance as of 31 December 2022

393

36,326

13,485

7,157

57,361

CHF m

Share capital

Statutory capital reserve

Voluntary earnings

reserve and

profit / (loss)

carried forward

Net profit / (loss)

for the period

Total equity

 

 

 

 

 

 

Balance as of 1 January 2022

386

35,649

7,552

6,013

49,599

Dividend distribution

 

 

(4,087)

 

(4,087)

Net profit / (loss) appropriation

 

 

6,013

(6,013)

0

Net profit / (loss) for the period

 

 

 

6,817

6,817

Currency translation difference

 

 

690

 

690

Balance as of 31 December 2022

386

35,649

10,167

6,817

53,018

 

 

 

Statement of proposed appropriation of total profit and dividend distribution

The Board of Directors (the BoD) proposes that the Annual General Meeting of Shareholders (the AGM) on 4 April 2023 approve the appropriation of total profit and an ordinary dividend distribution of USD 6,000m out of the total profit as follows:

 

Appropriation of and distribution out of total profit

 

 

USD m

 

CHF m

 

 

For the year ended

 

For the year ended

 

 

31.12.22

 

31.12.22

Net profit for the period

 

7,157

 

6,817

Profit / (loss) carried forward

 

0

 

0

Total profit available for appropriation

 

7,157

 

6,817

Appropriation to voluntary earnings reserve

 

(1,157)

 

(1,271)

Dividend distribution

 

(6,000)

 

(5,546)1

Profit / (loss) carried forward

 

0

 

0

1 For illustrative purposes, converted at closing exchange rate as of 31 December 2022 (CHF / USD 1.08).

 

The ordinary dividend distribution is declared and paid in US dollars. The total amount of the dividend distribution is capped at CHF 12,000m (the Cap). To the extent that the Swiss franc equivalent of the total dividend distribution of USD 6,000m would exceed the Cap on the day of the AGM, based on the exchange rate determined by the BoD in its reasonable opinion, the US dollar per share amount of the dividend will be reduced on a pro rata basis so that the total Swiss franc amount does not exceed the Cap. To the extent the Swiss franc equivalent of the total dividend distribution exceeds CHF 6,817m but does not exceed the Cap, the total dividend distribution in US dollars remains as is and is booked against the total profit in US dollars, while the Swiss franc currency difference of maximum CHF 5,183m is balanced through the Swiss franc translation of the voluntary earnings reserve account.

 

UBS AG standalone financial statements (audited)                                                                                                                                                         4 


     

Note 1  Name, legal form and registered office

UBS AG is incorporated and domiciled in Switzerland. Its registered offices are at Bahnhofstrasse 45, CH-8001 Zurich and Aeschenvorstadt 1, CH-4051 Basel, Switzerland. UBS AG operates under Art. 620 et seq. of the Swiss Code of Obligations and Swiss banking law as an Aktiengesellschaft, a corporation limited by shares.

UBS AG is a regulated bank in Switzerland and is 100% owned by UBS Group AG, the ultimate parent of the UBS Group. UBS AG holds investments in and provides funding to subsidiaries, including the other banking subsidiaries of the UBS Group. In addition, UBS AG operates globally, including business activities from all four UBS business divisions and Group Functions. In the ordinary course of business, the main contributors to the net profit / (loss) of UBS AG are the Investment Bank, Global Wealth Management, Group Treasury and Group Services. The balance sheet is mainly composed of financial assets and liabilities from the Investment Bank, Group Treasury and Global Wealth Management businesses booked outside of Switzerland, as well as investments in subsidiaries and other participations in Group Treasury and fixed assets of Group Services.

UBS AG employed 10,333 personnel on a full-time equivalent basis as of 31 December 2022, compared with 10,169 personnel as of 31 December 2021.

 

 

 

Note 2  Accounting policies

 

a) Significant accounting policies

UBS AG standalone financial statements are prepared in accordance with Swiss GAAP (the FINMA Accounting Ordinance, FINMA Circular 2020/1 “Accounting – banks” and the Banking Ordinance) and represent “reliable assessment statutory single-entity financial statements.” The accounting policies are principally the same as those outlined in Note 1 to the consolidated financial statements of UBS AG included in the UBS Group AG and UBS AG Annual Report 2022. Major differences between the Swiss GAAP requirements and International Financial Reporting Standards (IFRS) are described in Note 33 to the consolidated financial statements of UBS AG. The significant accounting policies applied for the standalone financial statements of UBS AG are discussed below.

    Refer to the UBS Group AG and UBS AG Annual Report 2022 for more information

Risk management

UBS AG is fully integrated into the Group-wide risk management process described in the audited part of the “Risk management and control” section of the UBS Group AG and UBS AG Annual Report 2022.

Further information about the use of derivative instruments and hedge accounting is provided on the following pages and in Notes 1, 10 and 25 to the consolidated financial statements of UBS AG.

    Refer to the UBS Group AG and UBS AG Annual Report 2022 for more information

Compensation policy

The compensation structure and processes of UBS AG conform to the compensation principles and framework of UBS Group AG. For detailed information, refer to the Compensation Report of UBS Group AG.

Deferred compensation

Expenses for deferred compensation awards granted by UBS Group AG to employees of UBS AG in the form of UBS shares, notional investment funds and notional additional tier 1 (AT1) capital instruments are charged by UBS Group AG to UBS AG.

    Refer to Note 27 to the UBS AG consolidated financial statements in the UBS Group AG and UBS AG Annual Report 2022 for more information

Foreign currency translation

Non-US dollar-denominated transactions are translated into US dollars at the spot exchange rate on the date of the transaction. At the balance sheet date, all non-US dollar-denominated monetary assets and liabilities, as well as non-US dollar-denominated equity instruments recorded in Trading portfolio assets and Financial investments, are translated into US dollars using the closing exchange rate. Non-monetary items measured at historic cost are translated at the spot exchange rate on the date of the transaction. Assets and liabilities of branches with functional currencies other than the US dollar are translated into US dollars at the closing exchange rate. Income and expense items of such branches are translated at weighted-average exchange rates for the period. All currency translation effects are recognized in the income statement.

The main currency translation rates used by UBS AG are provided in Note 32 of the consolidated financial statements of UBS AG.

    Refer to the UBS Group AG and UBS AG Annual Report 2022 for more information

 

UBS AG standalone financial statements (audited)                                                                                                                                                         5 


     

Note 2  Accounting policies (continued)

Presentation currencies

As the primary presentation currency of the financial statements of UBS AG is the US dollar, amounts in Swiss francs are additionally presented for each component of the financial statements. UBS AG applies the modified closing rate method for converting the US dollar presentation currency amounts into Swiss francs: assets and liabilities are converted at the closing rate, equity positions at historic rates, and income and expense items at the weighted-average rate for the period. The resulting currency translation effects are recognized separately in the Voluntary earnings reserve, amounting to a negative currency translation effect of CHF 2,929m as of 31 December 2022 (negative CHF 3,619m as of 31 December 2021).

Structured debt instruments

Structured debt instruments consist of debt instruments issued and transacted over the counter and include a host contract and one or more embedded derivatives that do not relate to UBS AG’s own equity. By applying the fair value option, the vast majority of structured debt instruments are measured at fair value as a whole and recognized in Financial liabilities designated at fair value. The fair value option for structured debt instruments can be applied only if the following criteria are cumulatively met:

     the structured debt instrument is measured on a fair value basis and is subject to risk management that is equivalent to risk management for trading activities;

     the application of the fair value option eliminates or significantly reduces an accounting mismatch that would otherwise arise; and

     changes in fair value attributable to changes in unrealized own credit are not recognized.

Fair value changes related to Financial liabilities designated at fair value, excluding changes in unrealized own credit, are recognized in Net trading income. Interest expense on Financial liabilities designated at fair value is recognized in Interest expense.

Where the designation criteria for the fair value option are not met, the embedded derivatives are assessed for bifurcation for measurement purposes. Bifurcated embedded derivatives are measured at fair value through profit or loss and presented in the same balance sheet line as the host contract.

    Refer to Note  20 for more information

Group-internal funding

UBS AG obtains funding from UBS Group AG in the form of loans that are subject to mandatory conversion and / or debt waiver, as explained below, and generally either qualify as loss-absorbing tier 1 capital or as gone concern loss-absorbing capacity, i.e., total funding eligible as total loss-absorbing capacity (TLAC), at the UBS AG consolidated and standalone levels. A portion of Group-internal funding obtained is further on lent by UBS AG to certain subsidiaries in the form of loans.

    Refer to Note 21 for information about funding eligible as total loss-absorbing capacity at the UBS AG level

UBS AG obligations arising from Group-internal funding it has received are presented as Funding received from UBS Group AG measured at amortized cost and Funding received from UBS Group AG within Financial liabilities designated at fair value. UBS AG claims arising from Group-internal funding it has provided are presented as Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity and are measured at amortized cost less any allowance for expected credit losses.

Subordinated assets and liabilities

Subordinated assets are composed of claims that, based on an irrevocable written declaration, in the event of liquidation, bankruptcy or composition concerning the debtor, rank after the claims of all other creditors and may not be offset against amounts payable to the debtor nor be secured by its assets. Subordinated liabilities are composed of corresponding obligations.

Subordinated assets and liabilities that contain a point-of-non-viability clause in accordance with Swiss capital requirements pursuant to Art. 29 and 30 of the Capital Adequacy Ordinance are disclosed as being Subject to mandatory conversion and / or debt waiver and provide for the claim or the obligation to be written off or converted into equity in the event that the issuing bank reaches a point of non-viability.

 

UBS AG standalone financial statements (audited)                                                                                                                                                         6 


     

 

Note 2  Accounting policies (continued)

Investments in subsidiaries and other participations

Investments in subsidiaries and other participations are equity interests that are held to carry on the business of UBS AG or for other strategic purposes. They include all subsidiaries directly held by UBS AG through which UBS AG conducts its business on a global basis. The investments are measured individually and carried at cost less impairment. The carrying amount is tested for impairment annually and when indicators of a potential decrease in value exist, which include significant operating losses incurred or a severe depreciation of the currency in which the investment is denominated. If an investment in a subsidiary is impaired, its value is generally written down to the net asset value. Subsequent recoveries in value are recognized up to the original cost value based on either the increased net asset value or a value above the net asset value if, in the opinion of management, forecasts of future profitability provide sufficient evidence that a carrying amount above net asset value is supported. Management may exercise its discretion as to what extent and in which period a recovery in value is recognized.

Impairments of investments are presented as Impairment of investments in subsidiaries and other participations and  reversals of impairments are presented as Extraordinary income in the income statement. Impairments and partial or full reversals of impairments for a subsidiary during the same annual period are determined on a net basis.

    Refer to Note 4 for more information

Hedge accounting for Investments in subsidiaries and other participations

UBS AG applies hedge accounting for certain investments in subsidiaries and other participations denominated in currencies other than the US dollar, which are designated as hedged items. For this purpose, foreign exchange (FX) derivatives, mainly FX forwards and FX swaps, are used and designated as hedging instruments.

The hedged risk is determined as the change in the carrying amount of the hedged item arising solely from changes in spot FX rates. Consequently, UBS AG only designates the spot element of the FX derivatives as hedging instruments. Changes in the fair value of the hedging instruments attributable to changes in forward points are not part of a hedge accounting designation. These amounts, therefore, do not form part of the effectiveness assessment and are recognized in Net trading income

The effective portion of gains and losses of these FX derivatives is deferred on the balance sheet as Other assets or Other liabilities to the extent no change is recognized in the carrying amount of the hedged item arising from changes in spot FX rates. Otherwise, the effective portion of gains and losses of these FX derivatives is matched with the corresponding valuation adjustments of the hedged item recorded in the income statement and recorded either as a reduction of Impairment of investments in subsidiaries and other participations or as Extraordinary income.

Revenue and expense transfers with other Group entities

UBS AG pays to and receives amounts from other Group entities in connection with revenue sharing arrangements, primarily related to the Investment Bank. Revenues transferred to and received from Group entities are settled in cash as hard revenue transfers paid or received. When the nature of the underlying transaction between UBS AG and the Group entity contains a single, clearly identifiable service component, related income and expenses are presented in the respective income statement line item, e.g., Fee and commission income from securities and investment business and other fee and commission income, Fee and commission expense or Net trading income. To the extent the nature of the underlying transaction contains various service components and is not clearly attributable to a particular income statement line item, related income and expenses are presented in Sundry ordinary income and Sundry ordinary expenses

UBS AG receives services from UBS Business Solutions AG, the main Group service company, mainly relating to the Chief Digital and Information Office, as well as certain other services from other Group entities.

UBS AG provides services to Group entities, mainly relating to real estate and selected other Group Services functions.

Services received from and provided to Group entities are settled in cash as hard cost transfers paid or received. Hard cost transfers paid are presented within General and administrative expenses and hard cost transfers received are presented within Sundry ordinary income or Income from real estate holdings

    Refer to Notes 5 and 7 for more information

 

UBS AG standalone financial statements (audited)                                                                                                                                                         7 


     

 

Note 2  Accounting policies (continued) 

Post-employment benefit plans

Swiss GAAP permit the use of IFRS or Swiss accounting standards for post-employment benefit plans, with the election made on a plan-by-plan basis.

UBS AG has elected to apply Swiss GAAP (FER 16) for the Swiss pension plan in its standalone financial statements. The requirements of Swiss GAAP (FER 16) are better aligned with the specific nature of Swiss pension plans, which are hybrid in that they combine elements of defined contribution and defined benefit plans but are treated as defined benefit plans under IFRS. Swiss GAAP (FER 16) require that the employer contributions to the pension fund are recognized as Personnel expenses in the income statement. The employer contributions to the Swiss pension fund are determined as a percentage of contributory compensation. Furthermore, Swiss GAAP (FER16) require an assessment as to whether, based on the financial statements of the pension fund prepared in accordance with Swiss accounting standards (FER 26), an economic benefit to, or obligation of, UBS AG arises from the pension fund that is recognized in the balance sheet when conditions are met. Conditions for recording a pension asset or liability would be met if, for example, an employer contribution reserve is available or UBS AG is required to contribute to the reduction of a pension deficit (on an FER 26 basis).

Key differences between Swiss GAAP (FER 16) and IFRS include the treatment of dynamic elements, such as future salary increases and future interest credits on retirement savings, which are not considered under the static method used in accordance with Swiss GAAP (FER 16). Also, the discount rate used to determine the defined benefit obligation in accordance with IFRS is based on the yield of high-quality corporate bonds of the market in the respective pension plan country. The discount rate used in accordance with Swiss GAAP (FER 16), i.e., the technical interest rate, is determined by the Pension Foundation Board, based on the expected returns of the Board’s investment strategy.

    Refer to Note 23 for more information

UBS AG has elected to apply IFRS (IAS 19) for its non-Swiss defined benefit plans. However, remeasurements of the defined benefit obligation and the plan assets are recognized in the income statement rather than directly in equity. For corresponding disclosures in accordance with IAS 19 requirements, refer to Note 26 to the consolidated financial statements of UBS AG.

    Refer to the UBS Group AG and UBS AG Annual Report 2022 for more information

Deferred taxes

Deferred tax assets are not recognized in UBS AG’s standalone financial statements. However, deferred tax liabilities may be recognized for taxable temporary differences. Changes in the deferred tax liability balance are recognized in the income statement.

Allowances and provisions for expected credit losses

UBS AG is required to apply expected credit loss (ECL) approaches for credit-impaired and non-credit-impaired financial instruments in its standalone financial statements.

For the substantial majority of non-credit-impaired exposures within the scope of the Swiss GAAP ECL requirements, UBS AG has chosen to apply the IFRS ECL approach that is also applied in its consolidated financial statements. These exposures include all financial assets that are measured at amortized cost under both frameworks, Swiss GAAP and IFRS, fee and lease receivables, claims arising from Group-internal funding presented as Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity, guarantees, irrevocable loan commitments, revolving revocable credit lines and forward starting reverse repurchase and securities borrowing agreements. Further information about the ECL approach under IFRS is provided in Note 1 to the consolidated financial statements of UBS AG.

    Refer to the UBS Group AG and UBS AG Annual Report 2022 for more information

For the small residual population of exposures within the scope of the Swiss GAAP ECL requirements, which are not subject to ECL under IFRS due to classification differences, alternative approaches are applied.

·           For exposures for which Pillar 1 internal ratings-based models are applied for measurement of credit risk RWA, ECL for such exposures is calculated as the regulatory expected loss (EL), with an add-on to scale up to the residual maturity of exposures maturing beyond the next 12 months. This approach is mainly applied for brokerage receivables presented within Due from customers, which  generally mature within 12 months. For detailed information about regulatory EL, refer to the “Risk management and control” section of the UBS Group AG and UBS AG Annual Report 2022.

·           For exposures for which the standardized approach is applied for the measurement of credit risk RWA, ECL is determined using a portfolio approach that derives a conservative probability of default (“PD”) and a conservative loss given default (“LGD”) for the entire portfolio. This approach is mainly applied for a small number of loans to large corporate clients presented within Due from customers.

 

UBS AG standalone financial statements (audited)                                                                                                                                                         8 


     

 

Note 2  Accounting policies (continued) 

UBS applies a single definition of default for credit risk management purposes, regulatory reporting and ECL, with a counterparty classified as defaulted based on quantitative and qualitative criteria.

    Refer to “Credit policies for distressed assets” in the “Risk management and control” section of the UBS Group AG Annual Report 2022 for more information

An allowance for credit losses is reported as a decrease in the carrying amount of a financial asset. For an off-balance sheet item, such as a commitment, a provision for credit losses is reported in Provisions. Changes to allowances and provisions for credit losses are recognized in Credit loss (expense) / release

    Refer to Note 13 for more information

Dispensations in the standalone financial statements

As UBS AG prepares consolidated financial statements in accordance with IFRS, UBS AG is exempt from various disclosures in the standalone financial statements. The dispensations include the management report, the statement of cash flows and various note disclosures, as well as the publication of full interim financial statements. As a Swiss issuer of debt, in order to validly issue debt throughout the year, UBS AG discloses interim mid-year financial information as per the requirements of Art. 1156 of the Swiss Code of Obligations in conjunction with Art. 652a thereof, including an income statement, a balance sheet and a note on the basis of accounting.

 

b) Changes in accounting policies

There were no significant changes in accounting policies during 2022.

 

 

Note 3a  Net trading income by business

 

 

USD m

 

CHF m

 

 

For the year ended

 

For the year ended

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Investment Bank

 

5,271

3,588

 

5,016

3,263

of which: Global Markets

 

5,423

3,632

 

5,165

3,303

of which: Global Banking

 

(152)

(44)

 

(148)

(40)

Other business divisions and Group Functions

 

525

35

 

496

38

Total net trading income

 

5,796

3,623

 

5,512

3,301

 

2021 included a loss of USD 861m (CHF 811m) incurred in the first half of 2021 in the Investment Bank on a default by a US-based client of UBS AG’s prime brokerage business.

 

 

Note 3b  Net trading income by underlying risk category

 

 

USD m

 

CHF m

 

 

For the year ended

 

For the year ended

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Equity instruments (including funds)

 

3,528

2,283

 

3,361

2,069

Foreign exchange instruments

 

1,404

978

 

1,341

896

Interest rate and credit instruments (including funds)

 

763

310

 

714

290

Other

 

100

51

 

97

47

Total net trading income

 

5,796

3,623

 

5,512

3,301

of which: net gains / (losses) from financial liabilities designated at fair value 1

 

12,687

(4,318)

 

12,184

(3,929)

1 Excludes fair value changes of hedges related to financial liabilities designated at fair value and foreign currency effects arising from translating foreign currency transactions into the respective functional currency, both of which are reported within Net trading income.

 

 

UBS AG standalone financial statements (audited)                                                                                                                                                         9 


     

Note 4  Investments in subsidiaries and other participations

 

The table below provides the carrying amount, the equity interest and the registered office information regarding the investments in subsidiaries and other participations.

 

 

Registered office

Equity interest accumulated in %

 

Carrying amount in USD m

 

Carrying amount in CHF m

 

 

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

UBS Americas Holding LLC

Wilmington, Delaware, USA

 100  

 

34,233

33,233

 

31,642

30,297

UBS Switzerland AG

Zurich, Switzerland

 100  

 

7,984

7,983

 

7,380

7,278

UBS Europe SE

Frankfurt, Germany

 100  

 

3,572

3,946

 

3,301

3,597

UBS Asset Management AG

Zurich, Switzerland

 100  

 

1,728

1,726

 

1,597

1,573

Other

 

 

 

3,511

3,784

 

3,246

3,449

Total investments in subsidiaries and other participations

 

 

 

51,029

50,671

 

47,165

46,195

 

 

Dividend income from investments in subsidiaries and other participations of USD 6,465m (CHF 6,183m) in 2022 and USD 6,401m (CHF 5,882m) in 2021 was mainly attributable to UBS Americas Holding LLC, UBS Switzerland AG, UBS Asset Management AG and UBS Europe SE.

In 2022 and 2021, UBS AG recognized Impairments of investments in subsidiaries and other participations of USD 1,056m (CHF 1,014m) and USD 1,187m (CHF 1,090m), respectively, mainly due to impairments related to UBS Europe SE (2022: USD 628m (CHF 609m), 2021: USD 1,063m (CHF 973m)), which partly offset the dividends received from this subsidiary.

 

 

Note 5  Sundry ordinary income and expenses

 

 

USD m

 

CHF m

 

 

For the year ended

 

For the year ended

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Income from services provided to UBS Group AG or its subsidiaries1

 

1,398

1,312

 

1,332

1,201

Other

 

69

30

 

65

28

Total sundry ordinary income

 

1,467

1,342

 

1,397

1,229

Expenses from revenue transfers to UBS Group AG or its subsidiaries

 

(629)

(289)

 

(596)

(262)

Net unrealized losses on financial investments2

 

(288)

(38)

 

(274)

(35)

Other

 

(20)

(11)

 

(19)

(10)

Total sundry ordinary expenses

 

(937)

(338)

 

(888)

(308)

1 Services provided by UBS AG primarily related to Group Functions.    2 Mainly relates to debt instruments available for sale. Refer to Note 16a for more information.

 

Note 6  Personnel expenses

 

 

USD m

 

CHF m

 

 

For the year ended

 

For the year ended

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Salaries

 

1,602

1,710

 

1,527

1,566

Variable compensation – performance awards

 

1,141

1,158

 

1,084

1,060

Variable compensation – other

 

76

53

 

72

48

Contractors

 

35

51

 

33

47

Social security

 

205

216

 

194

198

Post-employment benefit plans

 

(55)

(74)

 

(51)

(73)

of which: value adjustments for economic benefits or obligations from non-Swiss pension funds 1

 

(167)

(208)

 

(157)

(195)

Other personnel expenses

 

106

106

 

101

97

Total personnel expenses

 

3,109

3,221

 

2,960

2,943

1 Reflects the remeasurement of the defined benefit obligation and return on plan assets excluding amounts included in interest income for the non-Swiss defined benefit plans, for which IAS 19 is applied.

 

 

UBS AG standalone financial statements (audited)                                                                                                                                                         10 


     

 

Note 7  General and administrative expenses

 

 

USD m

 

CHF m

 

 

For the year ended

 

For the year ended

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Real estate

 

415

461

 

395

422

Market data services

 

108

108

 

103

99

IT expenses

 

92

90

 

87

83

Outsourcing costs

 

77

83

 

74

76

Marketing and communication

 

27

29

 

26

27

Travel and entertainment

 

41

18

 

39

16

Fees to audit firms

 

14

13

 

13

12

of which: financial and regulatory audits

 

11

11

 

10

10

of which: audit-related services

 

3

2

 

3

2

of which: tax and other services

 

0

0

 

0

0

Other professional fees

 

96

108

 

92

99

Other 

 

2,674

2,715

 

2,546

2,484

of which: shared services costs charged by UBS Group AG or its subsidiaries

 

2,465

2,524

 

2,349

2,310

Total general and administrative expenses

 

3,543

3,625

 

3,375

3,317

 

 

Note 8  Changes in provisions for litigation, regulatory and similar matters, and other provisions

 

Net expenses for provisions for litigation, regulatory and similar matters, and other provisions were USD 54m (CHF 50m) in 2022, compared with USD 862m (CHF 787m) in 2021, mainly as 2021 included a USD 755m (CHF 688m) increase in litigation provisions for the French cross-border matter.

    Refer to Note 17 to the UBS AG consolidated financial statements in the UBS Group AG and UBS AG Annual Report 2022 for more information

 

 

Note 9  Extraordinary income and expenses

 

 

USD m

 

CHF m

 

 

For the year ended

 

For the year ended

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Reversal of impairments of and provisions for subsidiaries and other participations1

 

5

161

 

4

151

Net gains from disposals of properties

 

80

114

 

74

104

Gains from disposals of subsidiaries and other participations

 

116

2

 

113

2

Other extraordinary income

 

1

5

 

0

5

Total extraordinary income

 

201

282

 

191

262

Total extraordinary expenses

 

2

1

 

2

1

1 Refer to Note 4 for more information.

 

Net gains from disposals of properties of USD 80m (CHF 74m) in 2022 and of USD 114m (CHF 104m) in 2021 mainly reflected gains on the sale of properties in Basel.

Gains from disposals of subsidiaries and other participations of USD 116m (CHF 113m) in 2022 mainly included a gain from the sale of UBS AG’s wholly owned subsidiary UBS Swiss Financial Advisers AG to Vontobel.

 

 

UBS AG standalone financial statements (audited)                                                                                                                                                         11 


     

 

Note 10  Taxes

 

 

USD m

 

CHF m

 

 

For the year ended

 

For the year ended

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Income tax expense / (benefit)

 

271

307

 

258

279

of which: current

 

250

282

 

237

256

of which: deferred

 

21

25

 

21

23

Capital tax

 

24

8

 

23

7

Total tax expense / (benefit)

 

295

315

 

281

286

 

Income tax expense of USD 271m (CHF 258m) was recognized for UBS AG in 2022, compared with USD 307m (CHF 279m) for 2021. The income tax expense for 2022 was reduced by a benefit of USD 204m (CHF 195m) in respect of the utilization of tax losses carried forward, primarily in the US and the UK. The income tax expense for 2022 related to UBS AG’s taxable profits that were primarily earned in other locations.

The income tax expense for 2021 was reduced by a benefit of USD 163m (CHF 149m) in respect of the utilization of tax losses carried forward, primarily in the US. The income tax expense for 2021 related to UBS AG’s taxable profits that were earned in other locations.

For 2022, the average tax rate, defined as income tax expense divided by the sum of operating profit and extraordinary income minus extraordinary expenses and capital tax, was 3.6% (2021: 4.5%).

 

 

Note 11  Securities financing transactions

 

 

USD bn

 

CHF bn

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

 

 

 

 

 

 

 

On-balance sheet

 

 

 

 

 

 

Receivables from securities financing transactions, gross

 

131.3

139.9

 

121.4

127.6

Netting of securities financing transactions

 

(73.2)

(83.6)

 

(67.7)

(76.2)

Receivables from securities financing transactions, net

 

58.1

56.3

 

53.7

51.4

 

 

 

 

 

 

 

Payables from securities financing transactions, gross

 

96.7

106.6

 

89.4

97.2

Netting of securities financing transactions

 

(73.2)

(83.6)

 

(67.7)

(76.2)

Payables from securities financing transactions, net

 

23.5

23.0

 

21.7

21.0

 

 

 

 

 

 

 

Assets pledged as collateral in connection with securities financing transactions

 

54.0

58.8

 

49.9

53.6

of which: trading portfolio assets

 

50.9

57.0

 

47.1

52.0

of which: assets that may be sold or repledged by counterparties

 

39.3

47.3

 

36.4

43.1

of which: financial investments

 

3.1

1.8

 

2.8

1.6

of which: assets that may be sold or repledged by counterparties

 

2.8

1.8

 

2.6

1.6

 

 

 

 

 

 

 

Off-balance sheet

 

 

 

 

 

 

Fair value of assets received as collateral in connection with securities financing transactions

 

312.8

343.5

 

289.1

313.2

of which: repledged

 

225.6

248.0

 

208.5

226.1

of which: sold in connection with short sale transactions

 

25.1

25.7

 

23.2

23.4

 

 

UBS AG standalone financial statements (audited)                                                                                                                                                         12 


     

 

Note 12a  Collateral for loans and off-balance sheet transactions

 

 

31.12.22

 

31.12.21

 

 

Secured

 

Unsecured

 

Total

 

Secured

 

Unsecured

 

Total

 

 

Secured by collateral

 

Secured by

other credit

enhancements2

 

 

 

 

 

Secured by collateral

 

Secured by

other credit

enhancements2

 

 

 

 

USD m

 

Real estate

 

Other

collateral1

 

 

 

 

 

 

Real estate

 

Other

collateral1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

On-balance sheet

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Due from customers, gross3

 

7

 

64,475

 

176

 

41,0694

 

105,726

 

4

 

85,928

 

192

 

35,9014

 

122,025

Mortgage loans, gross

 

5,039

 

 

 

 

 

 

 

5,039

 

5,496

 

 

 

 

 

 

 

5,496

of which: residential mortgages

 

3,205

 

 

 

 

 

 

 

3,205

 

4,233

 

 

 

 

 

 

 

4,233

of which: other mortgages5

 

1,834

 

 

 

 

 

 

 

1,834

 

1,263

 

 

 

 

 

 

 

1,263

Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

 

 

 

 

 

 

27,704

 

27,704

 

 

 

 

 

 

 

27,561

 

27,561

Total on-balance sheet, gross

 

5,045

 

64,475

 

176

 

68,772

 

138,469

 

5,500

 

85,928

 

192

 

63,463

 

155,083

Allowances

 

0

 

(54)

 

0

 

(145)

 

(200)

 

(4)

 

(78)

 

0

 

(167)

 

(249)

Total on-balance sheet, net

 

5,045

 

64,421

 

176

 

68,627

 

138,269

 

5,496

 

85,850

 

192

 

63,296

 

154,834

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Off-balance sheet

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent liabilities, gross

 

0

 

10,437

 

1,069

 

8,853

 

20,359

 

0

 

8,190

 

1,093

 

9,762

 

19,046

Irrevocable commitments, gross

 

237

 

7,467

 

129

 

8,440

 

16,272

 

253

 

8,192

 

226

 

8,723

 

17,394

Forward starting reverse repurchase and securities borrowing transactions

 

 

 

27,343

 

 

 

0

 

27,343

 

 

 

24,559

 

 

 

0

 

24,559

Liabilities for calls on shares and other equities

 

 

 

 

 

 

 

5

 

5

 

 

 

 

 

 

 

5

 

5

Total off-balance sheet

 

237

 

45,246

 

1,198

 

17,298

 

63,979

 

253

 

40,941

 

1,320

 

18,490

 

61,005

1 Mainly includes cash and securities.    2 Includes guarantees.    3 Includes prime brokerage margin lending receivables and prime brokerage receivables relating to securities financing transactions.    4 Primarily consists of amounts due from subsidiaries and other Group entities.    5 Consists of office and business premises, industrial premises and other mortgages.

 

 

 

 

31.12.22

 

31.12.21

 

 

Secured

 

Unsecured

 

Total

 

Secured

 

Unsecured

 

Total

 

 

Secured by collateral

 

Secured by

other credit

enhancements2

 

 

 

 

 

Secured by collateral

 

Secured by

other credit

enhancements2

 

 

 

 

CHF m

 

Real estate

 

Other

collateral1

 

 

 

 

 

 

Real estate

 

Other

collateral1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

On-balance sheet

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Due from customers, gross3

 

6

 

59,594

 

163

 

37,9594

 

97,722

 

4

 

78,338

 

175

 

32,7304

 

111,247

Mortgage loans, gross

 

4,657

 

 

 

 

 

 

 

4,657

 

5,011

 

 

 

 

 

 

 

5,011

of which: residential mortgages

 

2,962

 

 

 

 

 

 

 

2,962

 

3,859

 

 

 

 

 

 

 

3,859

of which: other mortgages5

 

1,695

 

 

 

 

 

 

 

1,695

 

1,151

 

 

 

 

 

 

 

1,151

Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

 

 

 

 

 

 

25,606

 

25,606

 

 

 

 

 

 

 

25,127

 

25,127

Total on-balance sheet, gross

 

4,663

 

59,594

 

163

 

63,565

 

127,985

 

5,014

 

78,338

 

175

 

57,857

 

141,384

Allowances

 

0

 

(50)

 

0

 

(135)

 

(185)

 

(3)

 

(71)

 

0

 

(152)

 

(227)

Total on-balance sheet, net

 

4,663

 

59,544

 

163

 

63,430

 

127,801

 

5,011

 

78,267

 

175

 

57,705

 

141,157

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Off-balance sheet

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent liabilities, gross

 

0

 

9,646

 

988

 

8,183

 

18,818

 

0

 

7,467

 

997

 

8,900

 

17,364

Irrevocable commitments, gross

 

219

 

6,902

 

119

 

7,801

 

15,041

 

231

 

7,468

 

206

 

7,953

 

15,858

Forward starting reverse repurchase and securities borrowing transactions

 

 

 

25,273

 

 

 

0

 

25,273

 

 

 

22,390

 

 

 

0

 

22,390

Liabilities for calls on shares and other equities

 

 

 

 

 

 

 

4

 

4

 

 

 

 

 

 

 

4

 

4

Total off-balance sheet

 

219

 

41,821

 

1,107

 

15,988

 

59,135

 

231

 

37,325

 

1,203

 

16,857

 

55,616

1 Mainly includes cash and securities.    2 Includes guarantees.    3 Includes prime brokerage margin lending receivables and prime brokerage receivables relating to securities financing transactions.    4 Primarily consists of amounts due from subsidiaries and other Group entities.    5 Consists of office and business premises, industrial premises and other mortgages.

 

 

UBS AG standalone financial statements (audited)                                                                                                                                                         13 


     

 

Note 12b  Credit-impaired financial instruments

 

 

31.12.22

 

31.12.21

USD m

 

Gross credit- impaired financial instruments

Allowances and

provisions

Estimated liquidation

proceeds of collateral

Net credit- impaired financial instruments

 

Gross credit- impaired financial instruments

Allowances and

provisions

Estimated liquidation

proceeds of collateral

Net credit- impaired financial instruments

Amounts due from customers

 

318

105

213

0

 

395

147

184

63

Mortgage loans

 

185

0

184

0

 

118

4

114

0

Other assets

 

2

2

0

0

 

1

1

0

0

Guarantees and loan commitments

 

73

0

40

33

 

14

0

14

0

Total credit-impaired financial instruments1

 

577

107

437

33

 

528

153

312

63

1 Credit-impaired financial instruments are financial assets and off-balance sheet positions subject to incurred credit losses, also referred to as stage 3 positions.

 

 

 

31.12.22

 

31.12.21

CHF m

 

Gross credit- impaired financial instruments

Allowances and

provisions

Estimated liquidation

proceeds of collateral

Net credit- impaired financial instruments

 

Gross credit- impaired financial instruments

Allowances and

provisions

Estimated liquidation

proceeds of collateral

Net credit- impaired financial instruments

Amounts due from customers

 

294

97

197

0

 

360

134

168

58

Mortgage loans

 

171

0

170

0

 

108

4

104

0

Other assets

 

2

2

0

0

 

1

1

0

0

Guarantees and loan commitments

 

67

0

37

31

 

13

0

13

0

Total credit-impaired financial instruments1

 

534

99

404

31

 

481

139

285

58

1 Credit-impaired financial instruments are financial assets and off-balance sheet positions subject to incurred credit losses, also referred to as stage 3 positions.

 

 

Note 13  Allowances and provisions

Allowances and provisions of USD 2,237m (CHF 2,068m) as of 31 December 2022 included allowances and provisions for credit losses of USD 286m (CHF 266m). Allowances and provisions of USD 2,395m (CHF 2,184m) as of 31 December 2021 included allowances and provisions for credit losses of USD 336m (CHF 307m).

The 2022 decrease in allowances and provisions for credit losses of USD 49m (CHF 41m) included net credit loss releases of USD 18m (CHF 17m) primarily related to credit-impaired positions, as well as USD 31m (CHF 24m) for write-offs and other movements that did not impact the income statement.

Net credit loss releases in 2022 included a net release of USD 17m (CHF 16m) on credit-impaired positions, including a release for a single airline-related counterparty of USD 28m (CHF 27m) in the Investment Bank, and a net expense of USD 10m (CHF 10m) across a number of defaulted positions.

 

 

Note 13a  Allowances for credit losses

USD m

Balance

as of

31.12.21

Increase

recognized

in the

income

statement

Release

recognized

in the

income

statement

Write-offs

Recoveries

and past

due interest

Reclassifications / other

Foreign

currency

translation

Balance

as of

31.12.22

Default risk relating to on-balance sheet exposures

259

0

(18)

(22)

0

0

(8)

211

of which: incurred credit losses

153

0

(17)

(22)

0

0

(8)

107

of which: expected credit losses 1

106

0

(1)

0

0

0

0

104

Total allowances for credit losses

259

0

(18)

(22)

0

0

(8)

211

1 Includes ECL allowances where an approach other than IFRS ECL is applied of USD 0m as of 31 December 2022 (USD 4m as of 31 December 2021). Refer to Note 2 for more information.

 

 

CHF m

Balance

as of

31.12.21

Increase

recognized

in the

income

statement

Release

recognized

in the

income

statement

Write-offs

Recoveries

and past

due interest

Reclassifications / other

Foreign

currency

translation

Balance

as of

31.12.22

Default risk relating to on-balance sheet exposures

237

0

(17)

(21)

0

0

(4)

196

of which: incurred credit losses

139

0

(16)

(21)

0

0

(4)

99

of which: expected credit losses 1

98

0

(1)

0

0

0

1

97

Total allowances for credit losses

237

0

(17)

(21)

0

0

(4)

196

1 Includes ECL allowances where an approach other than IFRS ECL is applied of CHF 0m as of 31 December 2022 (CHF 4m as of 31 December 2021). Refer to Note 2 for more information.

 

UBS AG standalone financial statements (audited)                                                                                                                                                         14 


     

 

Note 13b  Provisions

USD m

Balance

as of

31.12.21

Increase

recognized

in the

income

statement

Release

recognized

in the

income

statement

Provisions

used in

conformity

with

designated

purpose

Recoveries

Reclassifications

Foreign

currency translation / other2

 Balance 

as of

31.12.22

Default risk related to off-balance sheet items and credit lines

77

0

0

0

0

0

(1)

76

of which: expected credit losses

77

0

0

0

0

0

(1)

76

Litigation, regulatory and similar matters

1,711

59

(5)

(35)

0

0

(86)

1,643

Restructuring

70

53

(12)

(58)

0

0

(2)

51

Real estate1

130

1

(5)

(15)

0

0

(2)

109

Employee benefits

25

7

(4)

0

0

0

(1)

27

Deferred taxes

71

21

0

0

0

0

0

92

Other

52

6

(27)

(2)

0

0

(1)

28

Total provisions

2,136

146

(52)

(111)

0

0

(93)

2,026

1 Includes provisions for onerous contracts of USD 51m as of 31 December 2022 (31 December 2021: USD 67m) and reinstatement cost provisions for leasehold improvements of USD 58m as of 31 December 2022 (31 December 2021: USD 63m).    2 Other mainly includes changes related to unwind of discounting.

 

 

CHF m

Balance

as of

31.12.21

Increase

recognized

in the

income

statement

Release

recognized

in the

income

statement

Provisions

used in

conformity

with

designated

purpose

Recoveries

Reclassifications

Foreign

currency translation / other2

 Balance 

as of

31.12.22

Default risk related to off-balance sheet items and credit lines

70

0

0

0

0

0

0

70

of which: expected credit losses

70

0

0

0

0

0

0

70

Litigation, regulatory and similar matters

1,560

55

(4)

(34)

0

0

(57)

1,518

Restructuring

64

50

(12)

(56)

0

0

0

47

Real estate1

119

1

(5)

(14)

0

0

0

101

Employee benefits

23

6

(4)

0

0

0

(1)

25

Deferred taxes

65

20

0

0

0

0

1

85

Other

47

5

(26)

(2)

0

0

1

26

Total provisions

1,947

137

(50)

(106)

0

0

(56)

1,872

1 Includes provisions for onerous contracts of CHF 47m as of 31 December 2022 (31 December 2021: CHF 61m) and reinstatement cost provisions for leasehold improvements of CHF 54m as of 31 December 2022 (31 December 2021: CHF 58m).    2 Other mainly includes changes related to unwind of discounting.

 

UBS AG standalone financial statements (audited)                                                                                                                                                         15 


     

 

Note 13c  Development of ECL allowances and provisions

USD m

Total

Stage 1

Stage 2

Stage 3

Balance as of 31 December 2021

 (336) 

 (148) 

 (35) 

 (153) 

Net movement from new and derecognized transactions1

 13 

 4 

 11 

 (2) 

of which: Large corporate clients

 11 

 2 

 11 

 (2) 

Remeasurements with stage transfers2

 (23) 

 13 

 (20) 

 (16) 

of which: Large corporate clients

 (30) 

 14 

 (29) 

 (15) 

Remeasurements without stage transfers3

 28 

 (4) 

 (3) 

 34 

of which: Large corporate clients

 24 

 (5) 

 (2) 

 31 

Model changes4

 0 

 1 

 (1) 

 0 

Total ECL allowance movements with profit or loss impact

 17 

 14 

 (13) 

 17 

Movements without profit or loss impact (write-off, FX and other)5

 31 

 1 

 0 

 30 

Balance as of 31 December 2022

 (287) 

 (132) 

 (47) 

 (107) 

1 Represents the increase and decrease in allowances and provisions resulting from financial instruments (including guarantees and facilities) that were newly originated, purchased or renewed and from the final derecognition of loans or facilities on their maturity date or earlier.    2 Represents the remeasurement between 12-month and lifetime ECL due to stage transfers.    3 Represents the change in allowances and provisions related to changes in model inputs or assumptions, including changes in forward-looking macroeconomic conditions, changes in the exposure profile, PD and LGD changes, and unwinding of the time value.    4 Represents the change in the allowances and provisions related to changes in models and methodologies.    5 Represents the decrease in allowances and provisions resulting from write-offs of the ECL allowance against the gross carrying amount when all or part of a financial asset is deemed uncollectible or forgiven and movements in foreign exchange rates.

 

 

CHF m

Total

Stage 1

Stage 2

Stage 3

Balance as of 31 December 2021

 (307) 

 (136) 

 (32) 

 (139) 

Net movement from new and derecognized transactions1

 12 

 4 

 11 

 (2) 

of which: Large corporate clients

 10 

 2 

 11 

 (2) 

Remeasurements with stage transfers2

 (21) 

 13 

 (19) 

 (15) 

of which: Large corporate clients

 (28) 

 13 

 (28) 

 (14) 

Remeasurements without stage transfers3

 27 

 (4) 

 (3) 

 33 

of which: Large corporate clients

 22 

 (4) 

 (2) 

 29 

Model changes4

 0 

 0 

 (1) 

 0 

Total ECL allowance movements with profit or loss impact

 17 

 13   

 (12)   

 16 

Movements without profit or loss impact (write-off, FX and other)5

 24 

 (1) 

 0 

 25 

Balance as of 31 December 2022

 (266) 

 (123) 

 (44) 

 (99) 

1 Represents the increase and decrease in allowances and provisions resulting from financial instruments (including guarantees and facilities) that were newly originated, purchased or renewed and from the final derecognition of loans or facilities on their maturity date or earlier.    2 Represents the remeasurement between 12-month and lifetime ECL due to stage transfers.    3 Represents the change in allowances and provisions related to changes in model inputs or assumptions, including changes in forward-looking macroeconomic conditions, changes in the exposure profile, PD and LGD changes, and unwinding of the time value.    4 Represents the change in the allowances and provisions related to changes in models and methodologies.    5 Represents the decrease in allowances and provisions resulting from write-offs of the ECL allowance against the gross carrying amount when all or part of a financial asset is deemed uncollectible or forgiven and movements in foreign exchange rates.

 

UBS AG standalone financial statements (audited)                                                                                                                                                         16 


     

 

Note 13c  Development of ECL allowances and provisions (continued)

USD m

Total

Stage 1

Stage 2

Stage 3

Balance as of 31 December 2020

 (556) 

 (193) 

 (65) 

 (298) 

Net movement from new and derecognized transactions1

 15 

 6 

 9 

 0 

of which: Large corporate clients

 1 

 (8) 

 9 

 0 

Remeasurements with stage transfers2

 (2) 

 1 

 7 

 (10) 

of which: Large corporate clients

 (1) 

 1 

 7 

 (8) 

Remeasurements without stage transfers3

 33 

 14 

 4 

 15 

of which: Large corporate clients

 9 

 (5) 

 3 

 10 

Model changes4

 32 

 23 

 9 

 0 

Total ECL allowance movements with profit or loss impact

 78 

 44   

 29   

 6 

Movements without profit or loss impact (write-off, FX and other)5

 142 

 1 

 0 

 140 

Balance as of 31 December 2021

 (336) 

 (148) 

 (35) 

 (153) 

1 Represents the increase and decrease in allowances and provisions resulting from financial instruments (including guarantees and facilities) that were newly originated, purchased or renewed and from the final derecognition of loans or facilities on their maturity date or earlier.    2 Represents the remeasurement between 12-month and lifetime ECL due to stage transfers.    3 Represents the change in allowances and provisions related to changes in model inputs or assumptions, including changes in forward-looking macroeconomic conditions, changes in the exposure profile, PD and LGD changes, and unwinding of the time value.    4 Represents the change in the allowances and provisions related to changes in models and methodologies.    5 Represents the decrease in allowances and provisions resulting from write-offs of the ECL allowance against the gross carrying amount when all or part of a financial asset is deemed uncollectible or forgiven and movements in foreign exchange rates.

 

 

CHF m

Total

Stage 1

Stage 2

Stage 3

Balance as of 31 December 2020

 (492) 

 (172) 

 (57) 

 (264) 

Net movement from new and derecognized transactions1

 14 

 5 

 8 

 0 

of which: Large corporate clients

 0 

 (8) 

 8 

 0 

Remeasurements with stage transfers2

 (2) 

 1 

 7 

 (9) 

of which: Large corporate clients

 (1) 

 1 

 7 

 (8) 

Remeasurements without stage transfers3

 31 

 13 

 3 

 14 

of which: Large corporate clients

 8 

 (4) 

 3 

 10 

Model changes4

 29 

 21 

 9 

 0 

Total ECL allowance movements with profit or loss impact

 72 

 41   

 27   

 5 

Movements without profit or loss impact (write-off, FX and other)5

 113 

 (6) 

 (2) 

 120 

Balance as of 31 December 2021

 (307) 

 (136) 

 (32) 

 (139) 

1 Represents the increase and decrease in allowances and provisions resulting from financial instruments (including guarantees and facilities) that were newly originated, purchased or renewed and from the final derecognition of loans or facilities on their maturity date or earlier.    2 Represents the remeasurement between 12-month and lifetime ECL due to stage transfers.    3 Represents the change in allowances and provisions related to changes in model inputs or assumptions, including changes in forward-looking macroeconomic conditions, changes in the exposure profile, PD and LGD changes, and unwinding of the time value.    4 Represents the change in the allowances and provisions related to changes in models and methodologies.    5 Represents the decrease in allowances and provisions resulting from write-offs of the ECL allowance against the gross carrying amount when all or part of a financial asset is deemed uncollectible or forgiven and movements in foreign exchange rates.

 

UBS AG standalone financial statements (audited)                                                                                                                                                         17 


     

 

Note 13d   Balance sheet and off-balance sheet positions subject to ECL

The tables below provide ECL exposure and allowance and provision information about financial instruments and certain non-financial instruments that are subject to ECL.

 

USD m

 

31.12.22

 

 

Carrying amount1

 

ECL allowances

Financial instruments measured at amortized cost

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Cash and balances at central banks

 

48,344

48,344

0

0

 

0

0

0

0

Due from banks

 

31,450

31,450

0

0

 

(5)

(5)

0

0

Receivables from securities financing transactions

 

58,141

58,141

0

0

 

(2)

(2)

0

0

Due from customers2

 

105,552

103,876

1,463

213

 

(174)

(59)

(9)

(105)

Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

27,678

27,678

0

0

 

(26)

(26)

0

0

Mortgage loans

 

5,039

4,837

17

184

 

0

0

0

0

Accrued income and prepaid expenses

 

1,872

1,863

9

0

 

0

0

0

0

Other assets3

 

939

939

0

0

 

(3)

(1)

0

(2)

Total on-balance sheet financial assets within the scope of ECL

 

279,015

277,128

1,490

397

 

(211)

(94)

(9)

(107)

 

 

 

 

 

 

 

 

 

 

 

 

 

Total exposure

 

ECL provisions

Off-balance sheet (within the scope of ECL)

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Contingent liabilities, gross

 

20,359

19,260

1,091

8

 

(3)

(2)

(1)

0

Irrevocable commitments, gross

 

16,272

14,474

1,734

64

 

(72)

(35)

(37)

0

Forward starting transactions (securities financing transactions)4

 

2,810

2,810

0

0

 

0

0

0

0

Credit lines

 

11,592

11,256

335

0

 

(1)

0

0

0

Irrevocable committed prolongation of existing loans

 

147

147

0

0

 

0

0

0

0

Total off-balance sheet financial instruments and credit lines within the scope of ECL

 

51,180

47,947

3,160

73

 

(76)

(38)

(38)

0

Total allowances and provisions

 

 

 

 

 

 

(287)

(132)

(47)

(107)

1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances.    2 Includes USD 0m ECL allowances where an approach other than “IFRS ECL” is applied. Refer to Note 2 for more information.    3 Includes components of other receivables due from UBS Group AG and subsidiaries in the UBS Group and other assets within the scope of ECL. Refer to Note 17a for more information.    4 Includes forward starting reverse repurchase agreements within the scope of ECL.  

 

 

CHF m

 

31.12.22

 

 

Carrying amount1

 

ECL allowances

Financial instruments measured at amortized cost

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Cash and balances at central banks

 

44,684

44,684

0

0

 

0

0

0

0

Due from banks

 

29,069

29,069

0

0

 

(5)

(5)

0

0

Receivables from securities financing transactions

 

53,739

53,739

0

0

 

(2)

(2)

0

0

Due from customers2

 

97,561

96,011

1,353

197

 

(161)

(55)

(9)

(97)

Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

25,582

25,582

0

0

 

(24)

(24)

0

0

Mortgage loans

 

4,657

4,471

16

170

 

0

0

0

0

Accrued income and prepaid expenses

 

1,730

1,722

8

0

 

0

0

0

0

Other assets3

 

867

867

0

0

 

(3)

(1)

0

(2)

Total on-balance sheet financial assets within the scope of ECL

 

257,890

256,146

1,377

367

 

(196)

(88)

(9)

(99)

 

 

 

 

 

 

 

 

 

 

 

 

 

Total exposure

 

ECL provisions

Off-balance sheet (within the scope of ECL)

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Contingent liabilities, gross

 

18,818

17,802

1,008

8

 

(3)

(2)

(1)

0

Irrevocable commitments, gross

 

15,041

13,378

1,603

60

 

(66)

(32)

(34)

0

Forward starting transactions (securities financing transactions)4

 

2,597

2,597

0

0

 

0

0

0

0

Credit lines

 

10,714

10,404

310

0

 

(1)

(1)

0

0

Irrevocable committed prolongation of existing loans

 

135

135

0

0

 

0

0

0

0

Total off-balance sheet financial instruments and credit lines within the scope of ECL

 

47,305

44,317

2,921

67

 

(70)

(35)

(35)

0

Total allowances and provisions

 

 

 

 

 

 

(266)

(123)

(44)

(99)

1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances.    2 Includes CHF 0m ECL allowances where an approach other than “IFRS ECL” is applied. Refer to Note 2 for more information.    3 Includes components of other receivables due from UBS Group AG and subsidiaries in the UBS Group and other assets within the scope of ECL. Refer to Note 17a for more information.    4 Includes forward starting reverse repurchase agreements within the scope of ECL.   

 

UBS AG standalone financial statements (audited)                                                                                                                                                         18 


     

 

Note 13d   Balance sheet and off-balance sheet positions subject to ECL (continued) 

USD m

 

31.12.21

 

 

Carrying amount1

 

ECL allowances

Financial instruments measured at amortized cost

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Cash and balances at central banks

 

53,760

53,760

0

0

 

0

0

0

0

Due from banks

 

33,330

33,330

0

0

 

(5)

(5)

0

0

Receivables from securities financing transactions

 

56,336

56,336

0

0

 

(2)

(2)

0

0

Due from customers2

 

121,812

119,892

1,672

247

 

(214)

(56)

(10)

(147)

Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

27,530

27,530

0

0

 

(32)

(32)

0

0

Mortgage loans

 

5,492

5,379

0

114

 

(4)

0

0

(4)

Accrued income and prepaid expenses

 

1,213

1,212

2

0

 

0

0

0

0

Other assets3

 

912

912

0

0

 

(2)

(1)

0

(1)

Total on-balance sheet financial assets within the scope of ECL

 

300,386

298,351

1,674

361

 

(259)

(96)

(10)

(153)

 

 

 

 

 

 

 

 

 

 

 

 

 

Total exposure

 

ECL provisions

Off-balance sheet (within the scope of ECL)

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Contingent liabilities, gross

 

19,046

18,860

176

10

 

(4)

(3)

(1)

0

Irrevocable commitments, gross

 

17,394

15,967

1,423

4

 

(72)

(49)

(24)

0

Forward starting transactions (securities financing transactions)4

 

1,097

1,097

0

0

 

0

0

0

0

Credit lines

 

8,388

7,966

422

0

 

(1)

(1)

(1)

0

Irrevocable committed prolongation of existing loans

 

736

736

0

0

 

0

0

0

0

Total off-balance sheet financial instruments and credit lines within the scope of ECL

 

46,662

44,627

2,021

14

 

(77)

(52)

(25)

0

Total allowances and provisions

 

 

 

 

 

 

(336)

(148)

(35)

(153)

1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances.    2 Includes USD 4m ECL allowances where an approach other than “IFRS ECL” is applied. Refer to Note 2 for more information.    3 Includes components of other receivables due from UBS Group AG and subsidiaries in the UBS Group and other assets within the scope of ECL. Refer to Note 17a for more information.    4 Includes forward starting reverse repurchase agreements within the scope of ECL.  

 

 

CHF m

 

31.12.21

 

 

Carrying amount1

 

ECL allowances

Financial instruments measured at amortized cost

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Cash and balances at central banks

 

49,012

49,012

0

0

 

0

0

0

0

Due from banks

 

30,386

30,386

0

0

 

(5)

(5)

0

0

Receivables from securities financing transactions

 

51,360

51,360

0

0

 

(2)

(2)

0

0

Due from customers2

 

111,052

109,302

1,524

225

 

(195)

(51)

(9)

(134)

Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

25,098

25,098

0

0

 

(29)

(29)

0

0

Mortgage loans

 

5,007

4,904

0

104

 

(4)

0

0

(4)

Accrued income and prepaid expenses

 

1,106

1,105

1

0

 

0

0

0

0

Other assets3

 

832

832

0

0

 

(2)

(1)

0

(1)

Total on-balance sheet financial assets within the scope of ECL

 

273,853

271,998

1,526

329

 

(237)

(89)

(9)

(139)

 

 

 

 

 

 

 

 

 

 

 

 

 

Total exposure

 

ECL provisions

Off-balance sheet (within the scope of ECL)

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Contingent liabilities, gross

 

17,364

17,194

160

9

 

(3)

(2)

(1)

0

Irrevocable commitments, gross

 

15,858

14,557

1,298

4

 

(65)

(44)

(21)

0

Forward starting transactions (securities financing transactions)4

 

1,000

1,000

0

0

 

0

0

0

0

Credit lines

 

7,647

7,263

384

0

 

(2)

(1)

(1)

0

Irrevocable committed prolongation of existing loans

 

671

671

0

0

 

0

0

0

0

Total off-balance sheet financial instruments and credit lines within the scope of ECL

 

42,540

40,685

1,842

13

 

(70)

(47)

(23)

0

Total allowances and provisions

 

 

 

 

 

 

(307)

(136)

(32)

(139)

1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances.    2 Includes CHF 4m ECL allowances where an approach other than “IFRS ECL” is applied. Refer to Note 2 for more information.    3 Includes components of other receivables due from UBS Group AG and subsidiaries in the UBS Group and other assets within the scope of ECL. Refer to Note 17a for more information.    4 Includes forward starting reverse repurchase agreements within the scope of ECL.   

 

UBS AG standalone financial statements (audited)                                                                                                                                                         19 


     

 

Note 13e   Financial assets subject to credit risk by rating category

The table below shows the credit quality and the maximum exposure to credit risk based on the Group’s internal credit rating system and year-end stage classification.

 

Financial assets subject to credit risk by rating category

USD m

 

31.12.22

Rating category

 

0–1

2–3

4–5

6–8

9–13

Credit-impaired (defaulted)

Total gross carrying amount

ECL allowances

Net carrying amount (maximum exposure to credit risk)

Financial instruments measured at amortized cost

 

 

 

 

 

 

 

 

 

 

Cash and balances at central banks

 

 48,227 

 117 

 0 

 0 

 0 

 0 

 48,344 

 0 

 48,344 

of which: stage 1

 

 48,227 

 117 

 0 

 0 

 0 

 0 

 48,344 

 0 

 48,344 

Due from banks

 

 867 

 29,915 

 640 

 0 

 33 

 0 

 31,455 

 (5) 

 31,450 

of which: stage 1

 

 867 

 29,915 

 640 

 0 

 33 

 0 

 31,455 

 (5) 

 31,450 

Receivables from securities financing transactions

 

 14,930 

 8,597 

 7,564 

 26,332 

 721 

 0 

 58,143 

 (2) 

 58,141 

of which: stage 1

 

 14,930 

 8,597 

 7,564 

 26,332 

 721 

 0 

 58,143 

 (2) 

 58,141 

Due from customers

 

 4,619 

 38,780 

 8,602 

 50,987 

 2,420 

 318 

 105,726 

 (174) 

 105,552 

of which: stage 1

 

 4,619 

 38,780 

 8,295 

 50,433 

 1,809 

 0 

 103,936 

 (59) 

 103,876 

of which: stage 2

 

 0 

 0 

 307 

 555 

 611 

 0 

 1,473 

 (9) 

 1,463 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 318 

 318 

 (105) 

 213 

Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

 0 

 27,704 

 0 

 0 

 0 

 0 

 27,704 

 (26) 

 27,678 

of which: stage 1

 

 0 

 27,704 

 0 

 0 

 0 

 0 

 27,704 

 (26) 

 27,678 

Mortgage loans

 

 0 

 1 

 302 

 4,063 

 488 

 185 

 5,039 

 0 

 5,039 

of which: stage 1

 

 0 

 1 

 302 

 4,045 

 488 

 0 

 4,837 

 0 

 4,837 

of which: stage 2

 

 0 

 0 

 0 

 17 

 0 

 0 

 17 

 0 

 17 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 185 

 185 

 0 

 184 

Accrued income and prepaid expenses

 

 130 

 671 

 352 

 687 

 33 

 0 

 1,872 

 0 

 1,872 

of which: stage 1

 

 130 

 671 

 351 

 681 

 31 

 0 

 1,863 

 0 

 1,863 

of which: stage 2

 

 0 

 0 

 0 

 6 

 2 

 0 

 9 

 0 

 9 

Other assets

 

 0 

 155 

 4 

 776 

 5 

 2 

 942 

 (3) 

 939 

of which: stage 1

 

 0 

 155 

 4 

 776 

 5 

 0 

 940 

 (1) 

 939 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 2 

 2 

 (2) 

 0 

Total in scope of ECL assets / ECL amounts by stages

 

 68,772 

 105,939 

 17,464 

 82,845 

 3,701 

 504 

 279,225 

 (211) 

 279,015 

 

 

Off-balance sheet positions and credit lines subject to expected credit loss by rating category

USD m

 

31.12.22

Rating category

 

0–1

2–3

4–5

6–8

9–13

Credit-impaired

(defaulted)

Total off-balance sheet exposure

(maximum exposure to credit risk)

ECL provisions

Off-balance sheet (within the scope of ECL)

 

 

 

 

 

 

 

 

 

Contingent liabilities, gross

 

 7,157 

 9,102 

 2,464 

 1,273 

 356 

 8 

 20,359 

 (3) 

of which: stage 1

 

 7,157 

 9,072 

 1,555 

 1,247 

 229 

 0 

 19,260 

 (2) 

of which: stage 2

 

 0 

 30 

 909 

 25 

 127 

 0 

 1,091 

 (1) 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 8 

 8 

 0 

Irrevocable commitments, gross

 

 1,239 

 5,068 

 3,146 

 1,895 

 4,860 

 64 

 16,272 

 (72) 

of which: stage 1

 

 1,239 

 4,948 

 3,030 

 1,771 

 3,485 

 0 

 14,474 

 (35) 

of which: stage 2

 

 0 

 120 

 115 

 124 

 1,375 

 0 

 1,734 

 (37) 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 64 

 64 

 0 

Forward starting transactions (securities financing transactions)

 

 1,790 

 2 

 11 

 1,007 

 0 

 0 

 2,810 

 0 

of which: stage 1

 

 1,790 

 2 

 11 

 1,007 

 0 

 0 

 2,810 

 0 

Credit lines

 

 0 

 3,868 

 687 

 5,851 

 1,186 

 0 

 11,592 

 (1) 

of which: stage 1

 

 0 

 3,825 

 616 

 5,700 

 1,115 

 0 

 11,256 

 0 

of which: stage 2

 

 0 

 43 

 71 

 150 

 71 

 0 

 335 

 0 

Irrevocable committed prolongation of existing loans

 

 0 

 147 

 0 

 0 

 0 

 0 

 147 

 0 

of which: stage 1

 

 0 

 147 

 0 

 0 

 0 

 0 

 147 

 0 

Total off-balance sheet financial instruments and credit lines

 

 10,186 

 18,186 

 6,307 

 10,026 

 6,402 

 73 

 51,180 

 (76) 

   

UBS AG standalone financial statements (audited)                                                                                                                                                         20 


     

 

Note 13e   Financial assets subject to credit risk by rating category (continued)

Financial assets subject to credit risk by rating category

CHF m

 

31.12.22

Rating category

 

0–1

2–3

4–5

6–8

9–13

Credit-impaired (defaulted)

Total gross carrying amount

ECL allowances

Net carrying amount (maximum exposure to credit risk)

Financial instruments measured at amortized cost

 

 

 

 

 

 

 

 

 

 

Cash and balances at central banks

 

 44,576 

 108 

 0 

 0 

 0 

 0 

 44,684 

 0 

 44,684 

of which: stage 1

 

 44,576 

 108 

 0 

 0 

 0 

 0 

 44,684 

 0 

 44,684 

Due from banks

 

 801 

 27,650 

 591 

 0 

 30 

 0 

 29,073 

 (5) 

 29,069 

of which: stage 1

 

 801 

 27,650 

 591 

 0 

 30 

 0 

 29,073 

 (5) 

 29,069 

Receivables from securities financing transactions

 

 13,799 

 7,946 

 6,991 

 24,338 

 667 

 0 

 53,741 

 (2) 

 53,739 

of which: stage 1

 

 13,799 

 7,946 

 6,991 

 24,338 

 667 

 0 

 53,741 

 (2) 

 53,739 

Due from customers

 

 4,269 

 35,844 

 7,950 

 47,127 

 2,237 

 294 

 97,722 

 (161) 

 97,561 

of which: stage 1

 

 4,269 

 35,844 

 7,667 

 46,614 

 1,672 

 0 

 96,067 

 (55) 

 96,011 

of which: stage 2

 

 0 

 0 

 283 

 513 

 565 

 0 

 1,361 

 (9) 

 1,353 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 294 

 294 

 (97) 

 197 

Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

 0 

 25,607 

 0 

 0 

 0 

 0 

 25,607 

 (24) 

 25,582 

of which: stage 1

 

 0 

 25,607 

 0 

 0 

 0 

 0 

 25,607 

 (24) 

 25,582 

Mortgage loans

 

 0 

 1 

 279 

 3,755 

 451 

 171 

 4,657 

 0 

 4,657 

of which: stage 1

 

 0 

 1 

 279 

 3,739 

 451 

 0 

 4,471 

 0 

 4,471 

of which: stage 2

 

 0 

 0 

 0 

 16 

 0 

 0 

 16 

 0 

 16 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 171 

 171 

 0 

 170 

Accrued income and prepaid expenses

 

 120 

 620 

 325 

 635 

 31 

 0 

 1,730 

 0 

 1,730 

of which: stage 1

 

 120 

 620 

 325 

 629 

 29 

 0 

 1,722 

 0 

 1,722 

of which: stage 2

 

 0 

 0 

 0 

 6 

 2 

 0 

 8 

 0 

 8 

Other assets

 

 0 

 143 

 4 

 717 

 4 

 1 

 870 

 (3) 

 867 

of which: stage 1

 

 0 

 143 

 4 

 717 

 4 

 0 

 869 

 (1) 

 867 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 1 

 2 

 (2) 

 0 

Total in scope of ECL assets / ECL amounts by stages

 

 63,565 

 97,918 

 16,141 

 76,573 

 3,421 

 466 

 258,085 

 (196) 

 257,890 

 

 

Off-balance sheet positions and credit lines subject to expected credit loss by rating category

CHF m

 

31.12.22

Rating category

 

0–1

2–3

4–5

6–8

9–13

Credit-impaired

(defaulted)

Total off-balance sheet exposure

(maximum exposure to credit risk)

ECL provisions

Off-balance sheet (within the scope of ECL)

 

 

 

 

 

 

 

 

 

Contingent liabilities, gross

 

 6,615 

 8,413 

 2,277 

 1,176 

 329 

 8 

 18,818 

 (3) 

of which: stage 1

 

 6,615 

 8,385 

 1,438 

 1,153 

 211 

 0 

 17,802 

 (2) 

of which: stage 2

 

 0 

 27 

 840 

 23 

 118 

 0 

 1,008 

 (1) 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 8 

 8 

 0 

Irrevocable commitments, gross

 

 1,145 

 4,684 

 2,907 

 1,752 

 4,492 

 60 

 15,041 

 (66) 

of which: stage 1

 

 1,145 

 4,574 

 2,801 

 1,637 

 3,221 

 0 

 13,378 

 (32) 

of which: stage 2

 

 0 

 111 

 107 

 115 

 1,271 

 0 

 1,603 

 (34) 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 60 

 60 

 0 

Forward starting transactions (securities financing transactions)

 

 1,655 

 2 

 10 

 931 

 0 

 0 

 2,597 

 0 

of which: stage 1

 

 1,655 

 2 

 10 

 931 

 0 

 0 

 2,597 

 0 

Credit lines

 

 0 

 3,575 

 635 

 5,408 

 1,096 

 0 

 10,714 

 (1) 

of which: stage 1

 

 0 

 3,536 

 569 

 5,269 

 1,030 

 0 

 10,404 

 (1) 

of which: stage 2

 

 0 

 40 

 66 

 139 

 66 

 0 

 310 

 0 

Irrevocable committed prolongation of existing loans

 

 0 

 135 

 0 

 0 

 0 

 0 

 135 

 0 

of which: stage 1

 

 0 

 135 

 0 

 0 

 0 

 0 

 135 

 0 

Total off-balance sheet financial instruments and credit lines

 

 9,415 

 16,810 

 5,829 

 9,267 

 5,917 

 67 

 47,305 

 (70) 

 

    Refer to Note 9 and Note 19 to the UBS AG consolidated financial statements in the UBS Group AG and UBS AG Annual Report 2022 for more information about ECL in accordance with IFRS

 

UBS AG standalone financial statements (audited)                                                                                                                                                         21 


     

 

Note 13e   Financial assets subject to credit risk by rating category (continued)

Financial assets subject to credit risk by rating category

USD m

 

31.12.21

Rating category

 

0–1

2–3

4–5

6–8

9–13

Credit-impaired (defaulted)

Total gross carrying amount

ECL allowances

Net carrying amount (maximum exposure to credit risk)

Financial instruments measured at amortized cost

 

 

 

 

 

 

 

 

 

 

Cash and balances at central banks

 

 53,680 

 80 

 0 

 0 

 0 

 0 

 53,760 

 0 

 53,760 

of which: stage 1

 

 53,680 

 80 

 0 

 0 

 0 

 0 

 53,760 

 0 

 53,760 

Due from banks

 

 466 

 32,410 

 454 

 0 

 4 

 0 

 33,335 

 (5) 

 33,330 

of which: stage 1

 

 466 

 32,410 

 454 

 0 

 4 

 0 

 33,335 

 (5) 

 33,330 

Receivables from securities financing transactions

 

 13,983 

 8,793 

 8,256 

 23,871 

 1,435 

 0 

 56,338 

 (2) 

 56,336 

of which: stage 1

 

 13,983 

 8,793 

 8,256 

 23,871 

 1,435 

 0 

 56,338 

 (2) 

 56,336 

Due from customers

 

 3,116 

 34,793 

 14,591 

 66,766 

 2,365 

 395 

 122,025 

 (214) 

 121,812 

of which: stage 1

 

 3,116 

 34,790 

 14,236 

 66,007 

 1,800 

 0 

 119,948 

 (56) 

 119,892 

of which: stage 2

 

 0 

 3 

 355 

 759 

 566 

 0 

 1,682 

 (10) 

 1,672 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 395 

 395 

 (147) 

 247 

Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

 0 

 27,561 

 0 

 0 

 0 

 0 

 27,561 

 (32) 

 27,530 

of which: stage 1

 

 0 

 27,561 

 0 

 0 

 0 

 0 

 27,561 

 (32) 

 27,530 

Mortgage loans

 

 0 

 2 

 457 

 4,919 

 1 

 118 

 5,496 

 (4) 

 5,492 

of which: stage 1

 

 0 

 1 

 457 

 4,919 

 1 

 0 

 5,379 

 0 

 5,379 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 118 

 118 

 (4) 

 114 

Accrued income and prepaid expenses

 

 47 

 225 

 327 

 582 

 33 

 0 

 1,213 

 0 

 1,213 

of which: stage 1

 

 47 

 225 

 327 

 581 

 32 

 0 

 1,212 

 0 

 1,212 

of which: stage 2

 

 0 

 0 

 0 

 1 

 1 

 0 

 2 

 0 

 2 

Other assets

 

 0 

 100 

 2 

 810 

 3 

 1 

 915 

 (2) 

 912 

of which: stage 1

 

 0 

 100 

 2 

 810 

 3 

 0 

 914 

 (1) 

 912 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 1 

 1 

 (1) 

 0 

Total in scope of ECL assets / ECL amounts by stages

 

 71,293 

 103,963 

 24,086 

 96,948 

 3,841 

 514 

 300,644 

 (259) 

 300,386 

 

 

Off-balance sheet positions and credit lines subject to expected credit loss by rating category

USD m

 

31.12.21

Rating category

 

0–1

2–3

4–5

6–8

9–13

Credit-impaired

(defaulted)

Total off- balance sheet exposure

(maximum exposure to credit risk)

ECL provisions

Off-balance sheet (within the scope of ECL)

 

 

 

 

 

 

 

 

 

Contingent liabilities, gross

 

 4,385 

 10,960 

 1,782 

 1,498 

 411 

 10 

 19,046 

 (4) 

of which: stage 1

 

 4,385 

 10,937 

 1,729 

 1,495 

 315 

 0 

 18,860 

 (3) 

of which: stage 2

 

 0 

 24 

 52 

 3 

 97 

 0 

 176 

 (1) 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 10 

 10 

 0 

Irrevocable commitments, gross

 

 1,778 

 5,058 

 3,316 

 2,082 

 5,156 

 4 

 17,394 

 (72) 

of which: stage 1

 

 1,778 

 4,792 

 3,107 

 1,758 

 4,532 

 0 

 15,967 

 (49) 

of which: stage 2

 

 0 

 266 

 209 

 324 

 624 

 0 

 1,423 

 (24) 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 4 

 4 

 0 

Forward starting transactions (securities financing transactions)

 

 0 

 0 

 0 

 1,097 

 0 

 0 

 1,097 

 0 

of which: stage 1

 

 0 

 0 

 0 

 1,097 

 0 

 0 

 1,097 

 0 

Credit lines

 

 6 

 3,314 

 135 

 3,771 

 1,161 

 0 

 8,388 

 (1) 

of which: stage 1

 

 6 

 3,266 

 8 

 3,567 

 1,119 

 0 

 7,966 

 (1) 

of which: stage 2

 

 0 

 48 

 127 

 204 

 42 

 0 

 422 

 (1) 

Irrevocable committed prolongation of existing loans

 

 0 

 736 

 0 

 0 

 0 

 0 

 736 

 0 

of which: stage 1

 

 0 

 736 

 0 

 0 

 0 

 0 

 736 

 0 

Total off-balance sheet financial instruments and credit lines

 

 6,168 

 20,069 

 5,233 

 8,448 

 6,729 

 14 

 46,662 

 (77) 

 

UBS AG standalone financial statements (audited)                                                                                                                                                         22 


     

 

Note 13e   Financial assets subject to credit risk by rating category (continued)

Financial assets subject to credit risk by rating category

CHF m

 

31.12.21

Rating category

 

0–1

2–3

4–5

6–8

9–13

Credit-impaired (defaulted)

Total gross carrying amount

ECL allowances

Net carrying amount (maximum exposure to credit risk)

Financial instruments measured at amortized cost

 

 

 

 

 

 

 

 

 

 

Cash and balances at central banks

 

 48,939 

 73 

 0 

 0 

 0 

 0 

 49,012 

 0 

 49,012 

of which: stage 1

 

 48,939 

 73 

 0 

 0 

 0 

 0 

 49,012 

 0 

 49,012 

Due from banks

 

 425 

 29,548 

 414 

 0 

 4 

 0 

 30,391 

 (5) 

 30,386 

of which: stage 1

 

 425 

 29,548 

 414 

 0 

 4 

 0 

 30,391 

 (5) 

 30,386 

Receivables from securities financing transactions

 

 12,748 

 8,016 

 7,527 

 21,763 

 1,308 

 0 

 51,362 

 (2) 

 51,360 

of which: stage 1

 

 12,748 

 8,016 

 7,527 

 21,763 

 1,308 

 0 

 51,362 

 (2) 

 51,360 

Due from customers

 

 2,841 

 31,719 

 13,302 

 60,868 

 2,156 

 360 

 111,247 

 (195) 

 111,052 

of which: stage 1

 

 2,841 

 31,717 

 12,978 

 60,176 

 1,641 

 0 

 109,353 

 (51) 

 109,302 

of which: stage 2

 

 0 

 2 

 324 

 692 

 516 

 0 

 1,533 

 (9) 

 1,524 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 360 

 360 

 (134) 

 225 

Funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

 0 

 25,127 

 0 

 0 

 0 

 0 

 25,127 

 (29) 

 25,098 

of which: stage 1

 

 0 

 25,127 

 0 

 0 

 0 

 0 

 25,127 

 (29) 

 25,098 

Mortgage loans

 

 0 

 1 

 416 

 4,485 

 1 

 108 

 5,011 

 (4) 

 5,007 

of which: stage 1

 

 0 

 1 

 416 

 4,485 

 1 

 0 

 4,903 

 0 

 4,904 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 108 

 108 

 (4) 

 104 

Accrued income and prepaid expenses

 

 43 

 205 

 298 

 531 

 30 

 0 

 1,106 

 0 

 1,106 

of which: stage 1

 

 43 

 205 

 298 

 530 

 29 

 0 

 1,105 

 0 

 1,105 

of which: stage 2

 

 0 

 0 

 0 

 1 

 1 

 0 

 1 

 0 

 1 

Other assets

 

 0 

 91 

 1 

 738 

 3 

 1 

 834 

 (2) 

 832 

of which: stage 1

 

 0 

 91 

 1 

 738 

 3 

 0 

 834 

 (1) 

 832 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 1 

 1 

 (1) 

 0 

Total in scope of ECL assets / ECL amounts by stages

 

 64,996 

 94,781 

 21,958 

 88,384 

 3,501 

 468 

 274,089 

 (237) 

 273,853 

 

 

Off-balance sheet positions and credit lines subject to expected credit loss by rating category

CHF m

 

31.12.21

Rating category

 

0–1

2–3

4–5

6–8

9–13

Credit-impaired

(defaulted)

Total off- balance sheet exposure

(maximum exposure to credit risk)

ECL provisions

Off-balance sheet (within the scope of ECL)

 

 

 

 

 

 

 

 

 

Contingent liabilities, gross

 

 3,997 

 9,992 

 1,624 

 1,366 

 375 

 9 

 17,364 

 (3) 

of which: stage 1

 

 3,997 

 9,971 

 1,577 

 1,363 

 287 

 0 

 17,194 

 (2) 

of which: stage 2

 

 0 

 22 

 47 

 3 

 88 

 0 

 160 

 (1) 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 9 

 9 

 0 

Irrevocable commitments, gross

 

 1,621 

 4,612 

 3,023 

 1,898 

 4,701 

 4 

 15,858 

 (65) 

of which: stage 1

 

 1,621 

 4,369 

 2,833 

 1,602 

 4,132 

 0 

 14,557 

 (44) 

of which: stage 2

 

 0 

 243 

 191 

 295 

 569 

 0 

 1,298 

 (21) 

of which: stage 3

 

 0 

 0 

 0 

 0 

 0 

 4 

 4 

 0 

Forward starting transactions (securities financing transactions)

 

 0 

 0 

 0 

 1,000 

 0 

 0 

 1,000 

 0 

of which: stage 1

 

 0 

 0 

 0 

 1,000 

 0 

 0 

 1,000 

 0 

Credit lines

 

 5 

 3,021 

 123 

 3,438 

 1,059 

 0 

 7,647 

 (2) 

of which: stage 1

 

 5 

 2,978 

 7 

 3,252 

 1,020 

 0 

 7,263 

 (1) 

of which: stage 2

 

 0 

 44 

 116 

 186 

 39 

 0 

 384 

 (1) 

Irrevocable committed prolongation of existing loans

 

 0 

 671 

 0 

 0 

 0 

 0 

 671 

 0 

of which: stage 1

 

 0 

 671 

 0 

 0 

 0 

 0 

 671 

 0 

Total off-balance sheet financial instruments and credit lines

 

 5,623 

 18,296 

 4,771 

 7,702 

 6,135 

 13 

 42,540 

 (70) 

 

UBS AG standalone financial statements (audited)                                                                                                                                                         23 


     

 

Note 14  Trading portfolio and other financial instruments measured at fair value

 

 

USD m

 

CHF m

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

Trading portfolio assets

 

98,566

119,795

 

91,104

109,213

of which: debt instruments1

 

12,088

18,045

 

11,173

16,451

of which: listed

 

9,618

12,750

 

8,890

11,624

of which: equity instruments

 

83,720

98,424

 

77,382

89,730

of which: precious metals and other physical commodities

 

2,757

3,326

 

2,549

3,032

Total assets measured at fair value

 

98,566

119,795

 

91,104

109,213

of which: fair value derived using a valuation model

 

9,635

15,028

 

8,906

13,700

of which: securities eligible for repurchase transactions in accordance with liquidity regulations 2

 

5,635

7,042

 

5,208

6,420

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Trading portfolio liabilities

 

25,058

25,711

 

23,160

23,440

of which: debt instruments1

 

8,234

7,549

 

7,610

6,882

of which: listed

 

7,738

7,293

 

7,153

6,649

of which: equity instruments

 

16,824

18,162

 

15,550

16,557

Financial liabilities designated at fair value3

 

70,603

73,081

 

65,258

66,625

Total liabilities measured at fair value

 

95,661

98,791

 

88,418

90,065

of which: fair value derived using a valuation model

 

75,024

78,092

 

69,344

71,194

1 Includes money market paper.    2 Consists of high-quality liquid debt securities that are eligible for repurchase transactions at the Swiss National Bank or other central banks.    3 Refer to Note 20 for more information.

 

UBS AG standalone financial statements (audited)                                                                                                                                                         24 


     

 

Note 15  Derivative instruments1

 

 

31.12.22

 

31.12.21

USD bn

 

Derivative

financial

assets

Derivative

financial

liabilities

 

Total notional values2

 

Derivative

financial

assets

Derivative

financial

liabilities

 

Total notional values

Interest rate contracts

 

 

 

 

 

 

 

 

 

 

Forwards3

 

0.3

0.2

 

821

 

0.1

0.3

 

476

Swaps

 

28.8

22.9

 

10,336

 

27.7

20.5

 

8,266

of which: designated in hedge accounting relationships

 

0.0

0.0

 

112

 

0.0

0.0

 

115

Futures

 

0.0

0.0

 

603

 

0.0

0.0

 

524

Over-the-counter (OTC) options

 

14.2

17.5

 

1,393

 

6.6

9.2

 

1,100

Exchange-traded options

 

0.2

0.2

 

136

 

0.1

0.1

 

196

Total

 

43.6

40.8

 

13,2894

 

34.6

30.1

 

10,562

Foreign exchange contracts

 

 

 

 

 

 

 

 

 

 

Forwards

 

26.5

28.6

 

1,765

 

23.8

23.8

 

2,053

of which: designated in hedge accounting relationships

 

0.0

0.0

 

0

 

0.0

0.0

 

0

Swaps

 

50.2

51.0

 

3,351

 

24.7

25.1

 

3,246

of which: designated in hedge accounting relationships

 

0.8

0.5

 

33

 

0.1

0.4

 

40

Futures

 

0.0

0.0

 

2

 

0.0

0.0

 

1

Over-the-counter (OTC) options

 

9.3

9.3

 

1,074

 

5.2

5.3

 

823

Exchange-traded options

 

0.1

0.2

 

10

 

0.0

0.1

 

10

Total

 

86.1

89.1

 

6,201

 

53.8

54.3

 

6,134

Equity contracts

 

 

 

 

 

 

 

 

 

 

Forwards

 

0.2

0.3

 

33

 

0.3

0.3

 

27

Swaps

 

5.7

6.9

 

223

 

5.0

9.7

 

279

Futures

 

 0.0 

0.0

 

50

 

 0.0 

0.0

 

67

Over-the-counter (OTC) options

 

2.8

4.6

 

144

 

4.8

6.5

 

170

Exchange-traded options

 

8.7

9.6

 

525

 

12.1

12.5

 

636

Total

 

17.4

21.4

 

975

 

22.3

29.1

 

1,178

Credit derivative contracts

 

 

 

 

 

 

 

 

 

 

Credit default swaps

 

0.9

1.0

 

76

 

1.2

1.4

 

88

Total return swaps

 

0.1

0.2

 

1

 

0.1

0.2

 

3

Other

 

0.0

0.0

 

2

 

0.0

0.0

 

5

Total

 

1.0

1.2

 

79

 

1.3

1.6

 

95

Commodity, precious metals and other contracts

 

 

 

 

 

 

 

 

 

 

Forwards5

 

0.1

0.1

 

64

 

0.1

0.1

 

51

Swaps

 

0.5

0.7

 

39

 

0.5

0.8

 

45

Futures

 

 0.0 

0.0

 

16

 

 0.0 

0.0

 

14

Over-the-counter (OTC) options

 

0.4

0.3

 

29

 

0.4

0.2

 

24

Exchange-traded options

 

0.3

0.3

 

6

 

0.6

0.4

 

2

Total

 

1.3

1.4

 

154

 

1.5

1.5

 

138

Total before netting

 

149.5

153.8

 

20,698

 

113.4

116.6

 

18,107

of which: trading derivatives

 

148.6

153.3

 

 

 

113.3

116.2

 

 

of which: fair value derived using a valuation model

 

147.8

152.4

 

 

 

112.7

115.6

 

 

of which: derivatives designated in hedge accounting relationships

 

0.8

0.5

 

 

 

0.1

0.4

 

 

of which: fair value derived using a valuation model

 

0.8

0.5

 

 

 

0.1

0.4

 

 

Netting with cash collateral payables / receivables

 

(20.9)

(22.5)

 

 

 

(13.9)

(14.8)

 

 

Replacement value netting

 

(113.8)

(113.8)

 

 

 

(87.6)

(87.6)

 

 

Total after netting

 

14.7

17.4

 

 

 

11.9

14.1

 

 

of which: with central clearing counterparties

 

0.9

0.2

 

 

 

0.5

0.4

 

 

of which: with bank and broker-dealer counterparties

 

4.3

2.8

 

 

 

4.0

3.0

 

 

of which: other client counterparties

 

9.6

14.5

 

 

 

7.5

10.7

 

 

1 Bifurcated embedded derivatives are presented on the same balance sheet lines as their host contracts and are excluded from this table. The replacement values and related notional values of these derivatives were not material for the periods presented.    2 Total notional values include USD 11trn (31 December 2021: USD 9trn) relating to derivatives that are cleared through either a central counterparty or an exchange. The fair value of these derivatives net of the corresponding cash margin was not material for any of the periods presented.    3 Includes forward rate agreements.    4 Notional amounts related to interest rate contracts increased by USD 2.7trn compared with 31 December 2021, mainly reflecting higher business volumes driven by elevated interest rate volatility and inflation, partly offset by compression activity.    5 Includes derivative loan commitments with notional values of USD 5bn as of 31 December 2022 (31 December 2021: USD 9bn) and negative replacement values of USD 43m (31 December 2021: USD 33m).

 

UBS AG standalone financial statements (audited)                                                                                                                                                         25 


     

 

Note 15  Derivative instruments (continued)1

 

 

31.12.22

 

31.12.21

CHF bn

 

Derivative

financial

assets

Derivative

financial

liabilities

 

Total notional values2

 

Derivative

financial

assets

Derivative

financial

liabilities

 

Total notional values

Interest rate contracts

 

 

 

 

 

 

 

 

 

 

Forwards3

 

0.3

0.1

 

759

 

0.1

0.2

 

434

Swaps

 

26.7

21.1

 

9,553

 

25.3

18.7

 

7,536

of which: designated in hedge accounting relationships

 

0.0

0.0

 

104

 

0.0

0.0

 

105

Futures

 

0.0

0.0

 

558

 

0.0

0.0

 

477

Over-the-counter (OTC) options

 

13.1

16.2

 

1,288

 

6.1

8.4

 

1,003

Exchange-traded options

 

0.2

0.2

 

126

 

0.1

0.1

 

179

Total

 

40.3

37.7

 

12,2834

 

31.5

27.4

 

9,629

Foreign exchange contracts

 

 

 

 

 

 

 

 

 

 

Forwards

 

24.5

26.5

 

1,631

 

21.7

21.7

 

1,872

of which: designated in hedge accounting relationships

 

0.0

0.0

 

0

 

0.0

0.0

 

0

Swaps

 

46.4

47.1

 

3,097

 

22.5

22.9

 

2,960

of which: designated in hedge accounting relationships

 

0.8

0.5

 

31

 

0.1

0.3

 

36

Futures

 

0.0

0.0

 

2

 

0.0

0.0

 

1

Over-the-counter (OTC) options

 

8.6

8.6

 

993

 

4.7

4.8

 

750

Exchange-traded options

 

0.1

0.2

 

9

 

0.0

0.1

 

9

Total

 

79.6

82.3

 

5,732

 

49.0

49.5

 

5,592

Equity contracts

 

 

 

 

 

 

 

 

 

 

Forwards

 

0.2

0.3

 

31

 

0.3

0.3

 

25

Swaps

 

5.2

6.3

 

206

 

4.6

8.9

 

254

Futures

 

 0.0 

0.0

 

46

 

 0.0 

0.0

 

61

Over-the-counter (OTC) options

 

2.6

4.2

 

133

 

4.4

6.0

 

155

Exchange-traded options

 

8.1

8.9

 

486

 

11.0

11.4

 

580

Total

 

16.1

19.8

 

901

 

20.3

26.5

 

1,074

Credit derivative contracts

 

 

 

 

 

 

 

 

 

 

Credit default swaps

 

0.8

0.9

 

70

 

1.1

1.3

 

80

Total return swaps

 

0.1

0.2

 

1

 

0.1

0.2

 

3

Other

 

0.0

0.0

 

2

 

0.0

0.0

 

4

Total

 

1.0

1.1

 

73

 

1.2

1.4

 

87

Commodity, precious metals and other contracts

 

 

 

 

 

 

 

 

 

 

Forwards5

 

0.1

0.1

 

59

 

0.1

0.1

 

47

Swaps

 

0.5

0.6

 

36

 

0.4

0.7

 

41

Futures

 

 0.0 

0.0

 

15

 

 0.0 

0.0

 

13

Over-the-counter (OTC) options

 

0.4

0.3

 

27

 

0.4

0.2

 

22

Exchange-traded options

 

0.3

0.3

 

5

 

0.5

0.4

 

2

Total

 

1.2

1.3

 

142

 

1.4

1.4

 

125

Total before netting

 

138.1

142.1

 

19,131

 

103.4

106.3

 

16,508

of which: trading derivatives

 

137.4

141.7

 

 

 

103.3

106.0

 

 

of which: fair value derived using a valuation model

 

136.6

140.8

 

 

 

102.8

105.4

 

 

of which: derivatives designated in hedge accounting relationships

 

0.8

0.5

 

 

 

0.1

0.3

 

 

of which: fair value derived using a valuation model

 

0.8

0.5

 

 

 

0.1

0.3

 

 

Netting with cash collateral payables / receivables

 

(19.3)

(20.8)

 

 

 

(12.7)

(13.5)

 

 

Replacement value netting

 

(105.2)

(105.2)

 

 

 

(79.9)

(79.9)

 

 

Total after netting

 

13.6

16.1

 

 

 

10.9

12.9

 

 

of which: with central clearing counterparties

 

0.8

0.2

 

 

 

0.5

0.4

 

 

of which: with bank and broker-dealer counterparties

 

4.0

2.6

 

 

 

3.6

2.7

 

 

of which: other client counterparties

 

8.8

13.4

 

 

 

6.8

9.8

 

 

1 Bifurcated embedded derivatives are presented on the same balance sheet lines as their host contracts and are excluded from this table. The replacement values and related notional values of these derivatives were not material for the periods presented.    2 Total notional values include CHF 10trn (31 December 2021: CHF 8trn) relating to derivatives that are cleared through either a central counterparty or an exchange. The fair value of these derivatives net of the corresponding cash margin was not material for any of the periods presented.    3 Includes forward rate agreements.    4 Notional amounts related to interest rate contracts increased by CHF 2.7trn compared with 31 December 2021, mainly reflecting higher business volumes driven by elevated interest rate volatility and inflation, partly offset by compression activity.    5 Includes derivative loan commitments with notional values of CHF 4bn as of 31 December 2022 (31 December 2021: CHF 8bn) and negative replacement values of CHF 40m (31 December 2021: CHF 30m).

 

UBS AG standalone financial statements (audited)                                                                                                                                                         26 


     

 

Note 16a  Financial investments by instrument type

 

 

31.12.22

 

31.12.21

USD m

 

Carrying amount

Fair value

 

Carrying amount

Fair value

Debt instruments

 

43,725

43,496

 

19,423

19,801

 of which: held to maturity

 

21,657

21,202

 

6,968

7,039

of which: available for sale

 

22,068

22,293

 

12,455

12,762

Equity instruments

 

20

22

 

58

67

of which: qualified participations 1

 

4

4

 

25

31

Other

 

1

1

 

1

1

Total financial investments

 

43,746

43,518

 

19,482

19,870

of which: securities eligible for repurchase transactions in accordance with liquidity regulations 2

 

38,452

38,020

 

16,253

16,332

1 Qualified participations are investments in which UBS AG holds 10% or more of the total capital or has at least 10% of total voting rights.    2 Consists of high-quality liquid debt securities that are eligible for repurchase transactions at the Swiss National Bank or other central banks.

 

 

 

31.12.22

 

31.12.21

CHF m

 

Carrying amount

Fair value

 

Carrying amount

Fair value

Debt instruments

 

40,414

40,203

 

17,707

18,052

 of which: held to maturity

 

20,018

19,597

 

6,353

6,417

of which: available for sale

 

20,397

20,606

 

11,354

11,635

Equity instruments

 

18

20

 

53

61

of which: qualified participations 1

 

4

4

 

23

28

Other

 

1

1

 

1

1

Total financial investments

 

40,434

40,224

 

17,761

18,115

of which: securities eligible for repurchase transactions in accordance with liquidity regulations 2

 

35,541

35,142

 

14,817

14,890

1 Qualified participations are investments in which UBS AG holds 10% or more of the total capital or has at least 10% of total voting rights.    2 Consists of high-quality liquid debt securities that are eligible for repurchase transactions at the Swiss National Bank or other central banks.

 

 

Note 16b  Financial investments by counterparty rating – debt instruments

 

 

USD m

 

CHF m

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Internal UBS rating1

 

 

 

 

 

 

0–1

 

36,214

14,047

 

33,472

12,806

2–3

 

7,193

5,365

 

6,649

4,891

4–5

 

237

0

 

219

0

6–8

 

0

0

 

0

0

9–13

 

0

0

 

0

0

Non-rated

 

81

11

 

75

10

Total financial investments

 

43,725

19,423

 

40,414

17,707

1 Refer to Note 19 for more information.

 

 

 

 

 

 

Note 17a  Other assets

 

 

USD m

 

CHF m

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Deferral position for hedging instruments

 

9,029

0

 

8,346

0

Deposits and collateral provided in connection with litigation, regulatory and similar matters1

 

2,197

1,515

 

2,030

1,381

Fee- and commission-related receivables

 

121

240

 

112

218

Net assets for defined benefit plans

 

322

232

 

298

211

VAT, withholding tax and other tax receivables

 

1,038

157

 

959

143

Other

 

809

784

 

746

714

of which: other receivables due from UBS Group AG and subsidiaries in the UBS Group

 

519

477

 

480

436

Total other assets2

 

13,516

2,927

 

12,491

2,667

1 Refer to item 1 in Note 17b to the UBS AG consolidated financial statements in the UBS Group AG and UBS AG Annual Report 2022 for more information.    2 Includes components of other receivables due from UBS Group AG and subsidiaries in the UBS Group and other assets totaling USD 939m (CHF 867m) as of 31 December 2022 (USD 912m (CHF 832m) as of 31 December 2021), which are within the scope of expected credit loss accounting. Refer to Note 13d for more information.

 

UBS AG standalone financial statements (audited)                                                                                                                                                         27 


     

 

Note 17b  Other liabilities

 

 

USD m

 

CHF m

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Deferral position for hedging instruments

 

0

630

 

0

575

Settlement and clearing accounts

 

102

105

 

95

96

Net defined benefit liabilities

 

65

83

 

60

75

VAT, withholding tax and other tax payables1

 

70

79

 

65

72

Other

 

1,345

1,408

 

1,243

1,283

of which: other payables due to UBS Group AG and subsidiaries in the UBS Group

 

814

960

 

753

876

Total other liabilities

 

1,582

2,305

 

1,462

2,100

1 Excludes capital tax payables.

 

 

 

 

 

Note 18  Pledged assets

 

The table below provides information about pledged assets, other than assets placed with central banks related to undrawn credit lines and for payment, clearing and settlement purposes (31 December 2022: USD 5.2bn (CHF 4.8bn), 31 December 2021: USD 4.4bn (CHF 4.0bn)) and those pledged in connection with securities financing transactions (refer to Note 11 for more information).

 

 

31.12.22

 

31.12.21

USD m

Carrying amount of

pledged assets

 

Carrying amount of

pledged assets

Securities1

 4,733 

 

 4,609 

Property2

 2,052 

 

 2,392 

Total pledged assets

 6,785 

 

 7,002 

1 Includes securities pledged for derivative transactions, where the replacement values are managed on a portfolio basis across counterparties and product types, and therefore there is no direct relationship between the specific collateral pledged and the associated liability.    2 These pledged properties serve as collateral for an existing mortgage loan from UBS Switzerland AG, the carrying amount of which was USD 2,651m as of 31 December 2022 (USD 2,879m as of 31 December 2021).

 

 

31.12.22

 

31.12.21

CHF m

Carrying amount of

pledged assets

 

Carrying amount of

pledged assets

Securities1

 4,374 

 

 4,202 

Property2

 1,897 

 

 2,181 

Total pledged assets

 6,271 

 

 6,383 

1 Includes securities pledged for derivative transactions, where the replacement values are managed on a portfolio basis across counterparties and product types, and therefore there is no direct relationship between the specific collateral pledged and the associated liability.    2 These pledged properties serve as collateral for an existing mortgage loan from UBS Switzerland AG, the carrying amount of which was CHF 2,450m as of 31 December 2022 (CHF 2,625m as of 31 December 2021).

 

UBS AG standalone financial statements (audited)                                                                                                                                                         28 


     

 

Note 19  Country risk of total assets

The table below provides a breakdown of total non-Swiss assets by credit rating, after netting of assets and liabilities as recognized on the balance sheet, but before other risk mitigants. The credit ratings reflect the sovereign credit rating of the country to which the ultimate risk of the underlying asset is related. The ultimate country of risk for unsecured loan positions is the domicile of the immediate borrower or, in the case of a legal entity, the domicile of the ultimate parent entity. For collateralized or guaranteed positions, the ultimate country of risk is the domicile of the provider of the collateral or guarantor or, if applicable, the domicile of the ultimate parent entity of the provider of the collateral or guarantor. For mortgage loans, the ultimate country of risk is the country where the real estate is located. Similarly, the ultimate country of risk for property and equipment is the country where the property and equipment are located. Assets for which Switzerland is the ultimate country of risk are provided separately at the bottom of the table in order to provide a reconciliation to total balance sheet assets.

    Refer to the “Risk management and control” section of the UBS Group AG and UBS AG Annual Report 2022 for more information

 

 

  

  

  

  

  

  

 

31.12.22

 

31.12.21

Classification

Internal UBS rating1

Description

Moody’s Investors

Service

S&P

Fitch

 

USD m

%

 

USD m

%

Low risk

0 and 1

Investment grade

Aaa

AAA

AAA

 

230,979

46

 

235,039

46

2

 

Aa1 to Aa3

AA+ to AA–

AA+ to AA–

 

96,069

19

 

115,906

23

Medium risk

3

 

A1 to A3

A+ to A–

A+ to A–

 

71,856

14

 

71,763

14

4

 

Baa1 to Baa2

BBB+ to BBB

BBB+ to BBB

 

8,013

2

 

11,065

2

5

 

Baa3

BBB–

BBB–

 

6,156

1

 

6,297

1

High risk

6

Sub-investment grade

Ba1

BB+

BB+

 

287

0

 

1,146

0

7

 

Ba2

BB

BB

 

566

0

 

599

0

8

 

Ba3

BB–

BB–

 

1,958

0

 

2,363

0

9

 

B1

B+

B+

 

868

0

 

1,015

0

Very high risk

10

 

B2

B

B

 

524

0

 

914

0

11

 

B3

B–

B–

 

20

0

 

126

0

12

 

Caa1 to Caa2

CCC+ to CCC

CCC+ to CCC

 

203

0

 

254

0

13

 

Caa3 to C

CCC– to C

CCC– to C

 

140

0

 

41

0

Distressed

Default

Defaulted

 

D

D

 

9

0

 

34

0

Subtotal

 

 

 

 

 

 

417,648

83

 

446,561

88

Switzerland

  

  

  

  

  

 

87,119

17

 

63,288

12

Total assets

 

 

 

 

 

 

504,767

100

 

509,851

100

1 Internal ratings are mapped to the external ratings in line with the table published in the “Risk management and control” section of the UBS Group AG and UBS AG Annual Report 2022.

 

  

  

  

  

  

  

 

31.12.22

 

31.12.21

Classification

Internal UBS rating1

Description

Moody’s Investors

Service

S&P

Fitch

 

CHF m

%

 

CHF m

%

Low risk

0 and 1

Investment grade

Aaa

AAA

AAA

 

213,488

46

 

214,277

46

2

 

Aa1 to Aa3

AA+ to AA–

AA+ to AA–

 

88,797

19

 

105,668

23

Medium risk

3

 

A1 to A3

A+ to A–

A+ to A–

 

66,416

14

 

65,424

14

4

 

Baa1 to Baa2

BBB+ to BBB

BBB+ to BBB

 

7,407

2

 

10,087

2

5

 

Baa3

BBB–

BBB–

 

5,690

1

 

5,741

1

High risk

6

Sub-investment grade

Ba1

BB+

BB+

 

265

0

 

1,044

0

7

 

Ba2

BB

BB

 

523

0

 

546

0

8

 

Ba3

BB–

BB–

 

1,810

0

 

2,154

0

9

 

B1

B+

B+

 

802

0

 

925

0

Very high risk

10

 

B2

B

B

 

485

0

 

834

0

11

 

B3

B–

B–

 

19

0

 

115

0

12

 

Caa1 to Caa2

CCC+ to CCC

CCC+ to CCC

 

187

0

 

232

0

13

 

Caa3 to C

CCC– to C

CCC– to C

 

129

0

 

37

0

Distressed

Default

Defaulted

 

D

D

 

8

0

 

31

0

Subtotal

 

 

 

 

 

 

386,026

83

 

407,115

88

Switzerland

  

  

  

  

  

 

80,524

17

 

57,698

12

Total assets

 

 

 

 

 

 

466,550

100

 

464,814

100

1 Internal ratings are mapped to the external ratings in line with the table published in the “Risk management and control” section of the UBS Group AG and UBS AG Annual Report 2022.

 

UBS AG standalone financial statements (audited)                                                                                                                                                         29 


     

 

Note 20  Structured debt instruments

The table below provides a breakdown of financial liabilities designated at fair value that are considered structured debt instruments.

 

 

 

USD m

 

CHF m

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Fixed-rate bonds with structured features

 

2,293

1,819

 

2,120

1,658

Structured debt instruments issued:

 

 

 

 

 

 

Equity-linked

 

41,926

46,834

 

38,752

42,698

Rates-linked

 

15,925

16,152

 

14,719

14,725

Credit-linked

 

2,281

1,506

 

2,108

1,373

Commodity-linked1

 

4,304

2,913

 

3,978

2,655

FX-linked

 

578

412

 

535

375

Funding received from UBS Group AG designated at fair value2

 

1,959

2,137

 

1,811

1,948

Structured over-the-counter (OTC) debt instruments

 

1,336

1,308

 

1,235

1,193

Total financial liabilities designated at fair value

 

70,603

73,081

 

65,258

66,625

1 Includes precious metals-linked debt instruments issued.    2 Refer to Note 21 for more information.

 

In addition to Financial liabilities designated at fair value, certain structured debt instruments were reported within the balance sheet lines Due to banks, Due to customers and Bonds issued. These instruments were bifurcated for measurement purposes. As of 31 December 2022, the total carrying amount of the host instruments was USD 5,379m (CHF 4,972m) (31 December 2021: USD 7,613m (CHF 6,941m)) and the total carrying amount of the bifurcated embedded derivatives was positive USD 59m (CHF 54m) (31 December 2021: positive USD 57m (CHF 52m)).

 

 

 

Note 21  Funding eligible as total loss-absorbing capacity at the UBS AG level

 

 

USD m

 

CHF m

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Funding eligible as total loss-absorbing capacity at the UBS AG level included in:

 

 

 

 

 

 

Funding received from UBS Group AG measured at amortized cost

 

59,202

52,826

 

54,720

48,159

Funding received from UBS Group AG designated at fair value

 

1,959

2,137

 

1,811

1,948

Bonds issued

 

3,041

3,049

 

2,811

2,780

Total funding eligible as total loss-absorbing capacity at the UBS AG level1

 

64,202

58,011

 

59,342

52,887

1 Represents the Swiss GAAP carrying amount of instruments qualifying as total loss-absorbing capital. In accordance with the Basel III framework, as applicable to Swiss systemically relevant banks (SRB), total funding eligible as total loss-absorbing capacity at the UBS AG level was USD 58,823m (CHF 54,370m) as of 31 December 2022 (31 December 2021: USD 58,089m (CHF 52,958m)). Refer to the “UBS AG standalone regulatory information” section of this report for more information about Swiss SRB going and gone concern capital.

 

 

UBS AG standalone financial statements (audited)                                                                                                                                                         30 


     

 

Note 22a  Share capital

UBS AG shares

As of 31 December 2022, UBS AG’s share capital of CHF 386m (unchanged from 31 December 2021 consisted of fully paid-up registered issued shares with a nominal value each of CHF 0.10, which each entitle the holder to one vote at the meeting of the shareholders of UBS AG, if entered into the share register as having the right to vote, as well as a proportionate share of distributed dividends. UBS AG’s shares are not subject to any restrictions or limitations on their transferability.

As of 31 December 2022, shares issued by UBS AG totaled 3,858,408,466 shares (unchanged from 31 December 2021). The shares were all dividend bearing and held by UBS Group AG.

Additionally, as of 31 December 2022, 380,000,000 registered shares with a nominal value of CHF 0.10 each were available to be issued out of conditional capital (unchanged from 31 December 2021) through the voluntary or mandatory exercise of conversion rights and / or warrants granted in connection with the issuance of bonds or similar financial instruments on national or international capital markets. 

Non-distributable reserves

Non-distributable reserves consist of 50% of the share capital of UBS AG, amounting to USD 197m (CHF 193m) as of 31 December 2022 (unchanged from 31 December 2021).

Share capital – planned conversion of nominal currency in 2023

Following revisions to Swiss corporate law that are effective from 1 January 2023, the BoD will propose at the 2023 AGM that the shareholder approves the conversion of the share capital currency of UBS AG from the Swiss franc to the US dollar. As a result, the capital contribution reserve of UBS AG would also be converted to US dollars. This would align the share capital currency with the financial statement presentation currency of UBS AG. If the change is approved, the share capital of UBS AG will be slightly reduced, to a nominal value per share of USD 0.10 (from CHF 0.10 currently), with the amount of the reduction allocated to the capital contribution reserve. If approved, the conversion will be implemented with retroactive effect as of 1 January 2023 for accounting purposes based on the closing exchange rate from 30 December 2022. Total equity reported for UBS AG will not change.

 

 

Note 22b  Significant shareholders

The sole direct shareholder of UBS AG is UBS Group AG, which holds 100% of UBS AG shares. These shares are entitled to voting rights. Indirect shareholders of UBS AG included in the table below are the direct shareholders of UBS Group AG (acting in their own name or in their capacity as nominees for other investors or beneficial owners) that were registered in the UBS Group AG share register with 3% or more of the share capital of UBS Group AG as of 31 December 2022 or as of 31 December 2021. The shares and share capital of UBS AG held by indirect shareholders, as shown in the table below, represent their relative holding of UBS Group AG shares. They do not have voting rights in UBS AG.

    Refer to Note 24 to the UBS Group AG standalone financial statements in the UBS Group AG Annual Report 2022 for more information about significant shareholders of UBS Group AG

 

 

 

31.12.22

 

31.12.21

USD m, except where indicated

 

Share capital held

Shares held (%)

 

Share capital held

Shares held (%)

Significant direct shareholder of UBS AG

 

 

 

 

  

  

UBS Group AG

 

393

100

 

393

100

Significant indirect shareholders of UBS AG

 

 

 

 

 

 

Chase Nominees Ltd., London

  

34

9

  

35

9

DTC (Cede & Co.), New York1

 

28

7

 

23

6

Nortrust Nominees Ltd., London

  

17

4

  

19

5

1 DTC (Cede & Co.), New York, “The Depository Trust Company,” is a US securities clearing organization.

 

 

 

31.12.22

 

31.12.21

CHF m, except where indicated

 

Share capital held

Shares held (%)

 

Share capital held

Shares held (%)

Significant direct shareholder of UBS AG

 

 

 

 

  

  

UBS Group AG

 

386

100

 

386

100

Significant indirect shareholders of UBS AG

 

 

 

 

 

 

Chase Nominees Ltd., London

  

33

9

  

34

9

DTC (Cede & Co.), New York1

 

27

7

 

22

6

Nortrust Nominees Ltd., London

  

17

4

  

19

5

1 DTC (Cede & Co.), New York, “The Depository Trust Company,” is a US securities clearing organization.

UBS AG standalone financial statements (audited)                                                                                                                                                         31 


     

Note 23  Swiss pension plan and non-Swiss defined benefit plans

 

a) Assets related to non-Swiss defined benefit plans

 

USD m

 

CHF m

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Net assets for non-Swiss defined benefit plans1

 

 322 

 232 

 

 298 

 211 

Total assets for non-Swiss defined benefit plans

 

 322 

 232 

 

 298 

 211 

1 As of 31 December 2022, USD 321m (CHF 297m) related to the UK defined benefit pension plan and USD 1m (CHF 1m) related to the US defined benefit pension plan. As of 31 December 2021, USD 192m (CHF 175m) related to the UK defined benefit pension plan and USD 39m (CHF 36m) related to the US defined benefit pension plan.

 

 

 

 

b) Liabilities related to Swiss pension plan and non-Swiss defined benefit plans

 

USD m

 

CHF m

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Provision for Swiss pension plan

 

 0 

 0 

 

 0 

 0 

Net defined benefit liabilities for non-Swiss defined benefit plans1

 

 65 

 83 

 

 60 

 75 

Total provision for Swiss pension plan and net defined benefit liabilities for non-Swiss defined benefit plans

 

 65 

 83 

 

 60 

 75 

Bank accounts at UBS and UBS debt instruments held by Swiss pension fund

 

 24 

 15 

 

 22 

 14 

UBS derivative financial instruments held by Swiss pension fund

 

 7 

 10 

 

 6 

 9 

Total liabilities related to Swiss pension plan and non-Swiss defined benefit plans

 

 95 

 108 

 

 88 

 98 

1 As of 31 December 2022, USD 37m (CHF 34m) related to the US plans and USD 14m (CHF 13m) related to the UK plan. As of 31 December 2021, USD 44m (CHF 40m) related to the US plans and USD 22m (CHF 20m) related to the UK plan.

 

 

 

 

c) Swiss pension plan

 

 

 

 

 

 

 

 

USD m

 

CHF m

 

 

As of or for the year ended

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Pension plan surplus1

 

 297 

 588 

 

 275 

 536 

Economic benefit / (obligation) of UBS AG

 

 0 

 0 

 

 0 

 0 

Change in economic benefit / (obligation) recognized in the income statement

 

 0 

 0 

 

 0 

 0 

Employer contributions in the period recognized in the income statement

 

 41 

 52 

 

 39 

 47 

Performance awards-related employer contributions accrued

 

 4 

 5 

 

 4 

 5 

Total pension expense recognized in the income statement within Personnel expenses

 

 45 

 58 

 

 42 

 52 

1 The pension plan surplus is determined in accordance with FER 26 and consists of the reserve for the fluctuation in asset value. The surplus did not represent an economic benefit for UBS AG in accordance with FER 16 both as of 31 December 2022 and 31 December 2021.

 

UBS AG has elected to apply FER 16 for its Swiss pension plan and IFRS (IAS 19) for its non-Swiss defined benefit plans. However, remeasurements of the defined benefit obligations for non-Swiss defined benefit plans are recognized in the income statement rather than directly in equity.

In 2022, a credit of USD 55m (CHF 51m) was recognized in the income statement, driven by a net gain related to the UK defined benefit plan that reflected an increase in the applicable discount rate, partly offset by a loss due to a negative return on plan assets and an increase in the applicable inflation rate. This net gain was partly offset by expenses related to the Swiss plan and other non-Swiss defined benefit plans.

    Refer to Note 2 for more information

    Refer to Note 26 to the UBS AG consolidated financial statements in the UBS Group AG and UBS AG Annual Report 2022 for more information about non-Swiss defined benefit plans in accordance with IFRS

The Swiss pension plan had no employer contribution reserve as of both 31 December 2022 and 31 December 2021.

 

 

UBS AG standalone financial statements (audited)                                                                                                                                                         32 


     

Note 24  Related parties

Transactions with related parties are conducted at internally agreed transfer prices or at arm’s-length terms and neither involve more than the normal risk of collectability nor contain any other unfavorable features for the firm. Loans, fixed advances and mortgages granted to non-independent members of the governing bodies in the ordinary course of business are also on substantially the same terms and conditions that are available to other employees, including interest rates and collateral. Independent members of the governing bodies are granted loans and mortgages in the ordinary course of business at general market conditions.

 

 

 

31.12.22

 

31.12.21

USD m

 

Amounts due from

 

Amounts due to

 

Amounts due from

 

Amounts due to

Qualified shareholders1

 

2,609

 

65,310

 

725

 

62,245

of which: due from / to customers

 

2,526

 

1,061

 

672

 

2,030

of which: funding received from UBS Group AG measured at amortized cost

 

 

 

61,202

 

 

 

57,078

of which: funding received from UBS Group AG designated at fair value

 

 

 

1,959

 

 

 

2,137

Subsidiaries

 

100,990

 

51,093

 

93,934

 

49,574

of which: due from / to banks

 

26,500

 

39,168

 

28,062

 

31,602

of which: due from / to customers

 

32,075

 

2,801

 

26,596

 

2,279

of which: receivables / payables from securities financing transactions

 

13,003

 

7,775

 

9,346

 

13,880

of which: funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

27,678

 

 

 

27,530

 

 

Affiliated entities2

 

332

 

420

 

345

 

336

of which: due from / to customers

 

219

 

208

 

316

 

130

Members of governing bodies3

 

33

 

 

 

34

 

 

External auditors

 

 

 

4

 

 

 

4

Other related parties4

 

6

 

2

 

1

 

2

1 The qualified shareholder of UBS AG is UBS Group AG.    2 Affiliated entities of UBS AG are all direct subsidiaries of UBS Group AG.    3 Members of governing bodies consist of the members of the Board of Directors and Group Executive Board of UBS Group AG and the members of the Board of Directors and Executive Board of UBS AG.    4 Includes amounts due to / from other participations.

 

 

 

31.12.22

 

31.12.21

CHF m

 

Amounts due from

 

Amounts due to

 

Amounts due from

 

Amounts due to

Qualified shareholders1

 

2,412

 

60,366

 

661

 

56,747

of which: due from / to customers

 

2,335

 

981

 

613

 

1,851

of which: funding received from UBS Group AG measured at amortized cost

 

 

 

56,568

 

 

 

52,036

of which: funding received from UBS Group AG designated at fair value

 

 

 

1,811

 

 

 

1,948

Subsidiaries

 

93,344

 

47,225

 

85,636

 

45,195

of which: due from / to banks

 

24,494

 

36,202

 

25,583

 

28,810

of which: due from / to customers

 

29,647

 

2,589

 

24,246

 

2,078

of which: receivables / payables from securities financing transactions

 

12,018

 

7,187

 

8,521

 

12,654

of which: funding provided to significant regulated subsidiaries eligible as total loss-absorbing capacity

 

25,582

 

 

 

25,098

 

 

Affiliated entities2

 

307

 

388

 

314

 

306

of which: due from / to customers

 

202

 

193

 

288

 

118

Members of governing bodies3

 

31

 

 

 

31

 

 

External auditors

 

 

 

4

 

 

 

3

Other related parties4

 

5

 

2

 

1

 

2

1 The qualified shareholder of UBS AG is UBS Group AG.    2 Affiliated entities of UBS AG are all direct subsidiaries of UBS Group AG.    3 Members of governing bodies consist of the members of the Board of Directors and Group Executive Board of UBS Group AG and the members of the Board of Directors and Executive Board of UBS AG.    4 Includes amounts due to / from other participations.

 

As of 31 December 2022, off-balance sheet positions related to subsidiaries amounted to USD 8.0bn (CHF 7.4bn) (31 December 2021: USD 9.2bn (CHF 8.4bn)), of which USD 6.2bn (CHF 5.7bn) was guarantees to third parties (31 December 2021: USD 7.8bn (CHF 7.1bn)) and USD 0.5bn (CHF 0.5bn) was loan commitments (31 December 2021: USD 0.8bn (CHF 0.7bn)).

 

UBS AG standalone financial statements (audited)                                                                                                                                                         33 


     

 

Note 25  Fiduciary transactions

 

 

USD m

 

CHF m

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Fiduciary deposits

 

84

63

 

78

57

of which: placed with third-party banks

 

84

63

 

78

57

of which: placed with subsidiaries and affiliated entities

 

0

0

 

0

0

Total fiduciary transactions

 

84

63

 

78

57

 

 

Fiduciary transactions encompass transactions entered into by UBS AG that result in holding or placing assets on behalf of individuals, trusts, defined benefit plans and other institutions. Unless the recognition criteria for the assets are satisfied, these assets and the related income are excluded from UBS AG’s balance sheet and income statement but are disclosed in this Note as off-balance sheet fiduciary transactions. Client deposits that are initially placed as fiduciary transactions with UBS AG may be recognized on UBS AG’s balance sheet in situations in which the deposit is subsequently placed within UBS AG. In such cases, these deposits are not reported in the table above.

 

Note 26a  Invested assets and net new money

 

 

USD bn

 

CHF bn

 

 

As of or for the year ended

 

As of or for the year ended

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Discretionary assets

 

53

67

 

48

61

Other invested assets

 

415

493

 

384

449

Total invested assets1

 

468

560

 

432

510

Net new money

 

(1)

18

 

(2)

16

1 Includes no double counts.

 

Note 26b  Development of invested assets

 

 

USD bn

 

CHF bn

 

 

31.12.22

31.12.21

 

31.12.22

31.12.21

Total invested assets at the beginning of the year1

 

560

598

 

510

529

Net new money

 

(1)

18

 

(2)

16

Market movements2

 

(81)

(48)

 

(75)

(43)

Foreign currency translation

 

(10)

(5)

 

(2)

10

Other effects

 

1

(3)

 

1

(2)

Total invested assets at the end of the year1

 

468

560

 

432

510

1 Includes no double counts.    2 Includes interest and dividend income.

    Refer to Note 31 to the UBS AG consolidated financial statements in the UBS Group AG and UBS AG Annual Report 2022 for more information

 

 

UBS AG standalone financial statements (audited)                                                                                                                                                         34 


     

UBS AG standalone financial statements (audited)                                                                                                                                                         35 


     

UBS AG standalone financial statements (audited)                                                                                                                                                         36 


     

UBS AG standalone financial statements (audited)                                                                                                                                                         37 


     

UBS AG standalone financial statements (audited)                                                                                                                                                         38 


     

UBS AG standalone financial statements (audited)                                                                                                                                                         39 


     

UBS AG standalone regulatory information

 

UBS AG standalone regulatory information

Key metrics of the fourth quarter of 2022

Quarterly | The table below is based on Basel Committee on Banking Supervision (BCBS) Basel III rules.

During the fourth quarter of 2022, common equity tier 1 (CET1) capital increased by USD 0.5bn to USD 54.0bn, mainly reflecting operating profit before tax, partly offset by additional accruals for capital returns to UBS Group AG. Tier 1 capital decreased by USD 1.3bn to USD 65.8bn, primarily driven by a USD 1.8bn decrease in additional tier 1 (AT1) capital, partly offset by the aforementioned increase in CET1 capital. The decrease in AT1 capital was mainly driven by our announcement on 5 December 2022 that we intended to redeem an AT1 capital instrument on 31 January 2023, the first call date (ISIN CH0400441280, with a nominal amount of USD 2.0bn, issued on 31 January 2018). This instrument ceased to be eligible as AT1 capital when the call was announced in December 2022. Total capital decreased by USD 1.3bn to USD 66.3bn, mainly reflecting the aforementioned decrease in tier 1 capital.

Phase-in risk-weighted assets (RWA) increased by USD 9.5bn to USD 332.9bn during the fourth quarter of 2022, primarily driven by increased participation RWA and, to a lesser extent, by increases across market risk, as well as credit and counterparty credit risk RWA, partly offset by a decrease in operational risk RWA.

Leverage ratio exposure increased by USD 22.2bn to USD 575.5bn, mainly driven by higher trading portfolio assets and purchases of high-quality liquid asset (HQLA) securities, partly offset by lower derivatives.

Correspondingly, the CET1 capital ratio of UBS AG decreased to 16.2% from 16.5%, reflecting the increase in RWA, partly offset by the increase in the CET1 capital. The firm’s Basel III leverage ratio decreased to 11.4% from 12.1%, reflecting the higher leverage ratio exposure and the decrease in tier 1 capital.

The quarterly average liquidity coverage ratio (the LCR) increase was driven by a decrease in the average net cash outflows of USD 2.2bn to USD 53.6bn, mainly due to higher inflows from intercompany funding to other UBS entities. The effect of the reduction in the average net cash outflows was partially offset by a decrease in the average HQLA of USD 4.2bn to USD 101.6bn due to higher funding consumption from the business divisions.

As of 31 December 2022, the net stable funding ratio (the NSFR) decreased by 0.9 percentage points to 90.8%, remaining above the prudential requirement communicated by the Swiss Financial Market Supervisory Authority (FINMA). The movement in the NSFR was driven by an increase in required stable funding of USD 16.9bn to USD 280.2bn, mainly due to higher trading assets and loans to customers, partly offset by decreased derivative balances. Available stable funding increased by USD 12.9bn to USD 254.4bn, largely driven by higher customer deposits and debt securities issued.

 

UBS AG standalone regulatory information                                                                                                                                                                   40 


     

KM1: Key metrics

 

 

 

 

 

USD m, except where indicated

 

 

31.12.22

30.9.22

30.6.22

31.3.22

31.12.21

Available capital (amounts)

 

 

 

 

 

1

Common Equity Tier 1 (CET1)1

 53,995 

 53,480 

 54,146 

 52,218 

 52,818 

1a

Fully loaded ECL accounting model CET1

 53,995 

 53,480 

 54,139 

 52,211 

 52,803 

2

Tier 11

 65,836 

 67,149 

 68,188 

 66,597 

 66,658 

2a

Fully loaded ECL accounting model Tier 1

 65,836 

 67,149 

 68,180 

 66,589 

 66,643 

3

Total capital1

 66,321 

 67,634 

 68,682 

 67,599 

 68,054 

3a

Fully loaded ECL accounting model total capital

 66,321 

 67,634 

 68,674 

 67,592 

 68,039 

Risk-weighted assets (amounts)2

 

 

 

 

 

4

Total risk-weighted assets (RWA)

 332,864 

 323,364 

 327,846 

 330,401 

 317,913 

4a

Minimum capital requirement3

 26,629 

 25,869 

 26,228 

 26,432 

 25,433 

4b

Total risk-weighted assets (pre-floor)

 332,864 

 323,364 

 327,846 

 330,401 

 317,913 

Risk-based capital ratios as a percentage of RWA2

 

 

 

 

 

5

CET1 ratio (%)1

 16.22 

 16.54 

 16.52 

 15.80 

 16.61 

5a

Fully loaded ECL accounting model CET1 ratio (%)

 16.22 

 16.54 

 16.51 

 15.80 

 16.61 

6

Tier 1 ratio (%)1

 19.78 

 20.77 

 20.80 

 20.16 

 20.97 

6a

Fully loaded ECL accounting model Tier 1 ratio (%)

 19.78 

 20.77 

 20.80 

 20.15 

 20.96 

7

Total capital ratio (%)1

 19.92 

 20.92 

 20.95 

 20.46 

 21.41 

7a

Fully loaded ECL accounting model total capital ratio (%)

 19.92 

 20.92 

 20.95 

 20.46 

 21.40 

Additional CET1 buffer requirements as a percentage of RWA

 

 

 

 

 

8

Capital conservation buffer requirement (%)

 2.50 

 2.50 

 2.50 

 2.50 

 2.50 

9

Countercyclical buffer requirement (%)

 0.06 

 0.02 

 0.02 

 0.02 

 0.02 

9a

Additional countercyclical buffer for Swiss mortgage loans (%)

 0.00 

 0.00 

 

 

 

10

Bank G-SIB and / or D-SIB additional requirements (%)4

 

 

 

 

 

11

Total of bank CET1 specific buffer requirements (%)5

 2.56 

 2.52 

 2.52 

 2.52 

 2.52 

12

CET1 available after meeting the bank’s minimum capital requirements (%)

 11.72 

 12.04 

 12.02 

 11.30 

 12.11 

Basel III leverage ratio

 

 

 

 

 

13

Total Basel III leverage ratio exposure measure

 575,461 

 553,215 

 569,794 

 594,893 

 593,868 

14

Basel III leverage ratio (%)1

 11.44 

 12.14 

 11.97 

 11.19 

 11.22 

14a

Fully loaded ECL accounting model Basel III leverage ratio (%)

 11.44 

 12.14 

 11.97 

 11.19 

 11.22 

Liquidity coverage ratio (LCR)6

 

 

 

 

 

15

Total high-quality liquid assets (HQLA)

 101,609 

 105,768 

 104,628 

 103,168 

 89,488 

16

Total net cash outflow

 53,616 

 55,770 

 55,405 

 55,039 

 52,229 

16a

of which: cash outflows

 156,764 

 155,688 

 159,568 

 162,735 

 163,207 

16b

of which: cash inflows

 103,148 

 99,919 

 104,163 

 107,696 

 110,978 

17

LCR (%)

191.19

 190.23 

 189.29 

 188.26 

 173.19 

Net stable funding ratio (NSFR)7

 

 

 

 

 

18

Total available stable funding

254,433

241,505

244,791

249,760

257,992

19

Total required stable funding

280,166

263,308

265,597

275,424

289,195

20

NSFR (%)

90.82

91.72

92.17

90.68

89.21

1 As of 1 July 2022, our capital amounts exclude the transitional relief of recognizing ECL allowances and provisions in CET1 capital in accordance with FINMA Circular 2013/1 “Eligible capital – banks.”    2 Based on phase-in rules for RWA. Refer to “Swiss SRB going and gone concern requirements and information” below for more information.    3 Calculated as 8% of total RWA, based on total capital minimum requirements, excluding CET1 buffer requirements.    4 Swiss SRB going and gone concern requirements and information for UBS AG standalone are provided below in this section.    5 Excludes non-BCBS capital buffer requirements for risk-weighted positions that are directly or indirectly backed by residential properties in Switzerland.    6 Calculated after the application of haircuts and inflow and outflow rates, as well as, where applicable, caps on Level 2 assets and cash inflows. Calculated based on an average of 63 data points in the fourth quarter of 2022 and 66 data points in the third quarter of 2022. For the prior-quarter data points, refer to the respective Pillar 3 Report, available under “Pillar 3 disclosures” at ubs.com/investors, for more information.    7 In accordance with Art. 17h para. 3 and 4 of the Liquidity Ordinance, UBS AG standalone is required to maintain a minimum NSFR of at least 80% without taking into account excess funding of UBS Switzerland AG and 100% after taking into account such excess funding.

p

 

UBS AG standalone regulatory information                                                                                                                                                                   41 


     

Swiss SRB going and gone concern requirements and information

UBS AG standalone is considered a systemically relevant bank (an SRB) under Swiss banking law and is subject to capital regulations on a standalone basis.

The capital requirements based on RWA include a minimum CET1 capital requirement of 10.06%, including a countercyclical buffer of 0.06%, and a total going concern capital requirement of 14.36%, including a countercyclical buffer of 0.06%. The capital requirements based on the leverage ratio denominator (the LRD) include a minimum CET1 capital requirement of 3.5% and a total going concern leverage ratio requirement of 5.0%.

CET1 and high-trigger AT1 capital instruments are eligible as going concern capital. As of 31 December 2022, one remaining outstanding low-trigger AT1 capital instrument, amounting to USD 1.2bn, that was on lent from UBS Group AG to UBS AG qualifies as going concern capital, as agreed with FINMA.

Currently, UBS AG standalone is subject to a gone concern capital requirement based on the sum of: (i) the capital requirements resulting from third-party exposure on a standalone basis; (ii) a buffer requirement equal to 30% of the Group’s gone concern capital requirement on UBS AG’s consolidated exposure; and (iii) the nominal value of the gone concern instruments issued by UBS entities and held by the parent bank. A transitional period until 2024 has been granted for the buffer requirement. The gone concern capital coverage ratio reflects how much gone concern capital is available to meet the gone concern requirement. Outstanding high- and low-trigger loss-absorbing tier 2 capital instruments, non-Basel III-compliant tier 2 capital instruments and total loss-absorbing capacity-eligible senior unsecured debt instruments are eligible to meet gone concern requirements until one year before maturity.

    Refer to “Significant regulatory developments, disclosure requirements and other changes to be adopted after 2022” in the “Introduction and basis for preparation” section of the 31 December 2022 Pillar 3 Report for more information about Revisions to the Swiss Banking Ordinance

For direct and indirect investments, including the holding of regulatory capital instruments of UBS AG by subsidiaries that are active in banking and finance, a FINMA decree introduced a risk-weighting approach, with a phase-in period until 1 January 2028. Starting from 1 July 2017, these investments were risk-weighted at 200%. From 1 January 2019 onward, the risk weights are being gradually raised by 5 percentage points per year for Switzerland-domiciled investments and by 20 percentage points per year for foreign-domiciled investments until the fully applied risk weights are 250% and 400%, respectively. As of 31 December 2022, the applicable phase-in risk weights are 220% for Switzerland-domiciled investments and 280% for foreign-domiciled investments.

    Refer to “Additional information” in the “Capital, liquidity and funding, and balance sheet” section of the UBS Group AG Annual Report 2022 for more information about the joint liability of UBS AG and UBS Switzerland AG

 

UBS AG standalone regulatory information                                                                                                                                                                   42 


     

Quarterly | The tables below provide details of the Swiss SRB RWA- and LRD-based going and gone concern requirements and information as required by FINMA; details regarding eligible gone concern instruments are provided below.

 

Swiss SRB going and gone concern requirements and information

As of 31.12.22

 

RWA, phase-in

 

RWA, fully applied as of 1.1.28

 

LRD

USD m, except where indicated

 

in %

 

 

in %

 

 

in %

 

Required going concern capital

 

 

 

 

 

 

 

 

 

Total going concern capital

 

 14.361

 47,800 

 

 14.361

 56,023 

 

 5.001

 28,773 

Common equity tier 1 capital

 

 10.06 

 33,486 

 

 10.06 

 39,247 

 

 3.50 

 20,141 

of which: minimum capital

 

 4.50 

 14,979 

 

 4.50 

 17,556 

 

 1.50 

 8,632 

of which: buffer capital

 

 5.50 

 18,307 

 

 5.50 

 21,457 

 

 2.00 

 11,509 

of which: countercyclical buffer

 

 0.06 

 200 

 

 0.06 

 234 

 

 

 

Maximum additional tier 1 capital

 

 4.30 

 14,313 

 

 4.30 

 16,776 

 

 1.50 

 8,632 

of which: additional tier 1 capital

 

 3.50 

 11,650 

 

 3.50 

 13,654 

 

 1.50 

 8,632 

of which: additional tier 1 buffer capital

 

 0.80 

 2,663 

 

 0.80 

 3,121 

 

 

 

 

 

 

 

 

 

 

 

 

 

Eligible going concern capital

 

 

 

 

 

 

 

 

 

Total going concern capital

 

 19.78 

 65,836 

 

 16.88 

 65,836 

 

 11.44 

 65,836 

Common equity tier 1 capital

 

 16.22 

 53,995 

 

 13.84 

 53,995 

 

 9.38 

 53,995 

Total loss-absorbing additional tier 1 capital

 

 3.56 

 11,841 

 

 3.04 

 11,841 

 

 2.06 

 11,841 

of which: high-trigger loss-absorbing additional tier 1 capital

 

 3.20 

 10,654 

 

 2.73 

 10,654 

 

 1.85 

 10,654 

of which: low-trigger loss-absorbing additional tier 1 capital

 

 0.36 

 1,187 

 

 0.30 

 1,187 

 

 0.21 

 1,187 

 

 

 

 

 

 

 

 

 

 

Risk-weighted assets / leverage ratio denominator

 

 

 

 

 

 

 

 

 

Risk-weighted assets

 

 

 332,864 

 

 

 390,128 

 

 

 

Leverage ratio denominator

 

 

 

 

 

 

 

 

 575,461 

 

 

 

 

 

 

 

 

 

 

Required gone concern capital2

 

Higher of RWA- or LRD-based

 

 

 

 

 

 

Total gone concern loss-absorbing capacity

 

 

 40,106 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Eligible gone concern capital

 

 

 

 

 

 

 

 

Total gone concern loss-absorbing capacity

 

 

 46,982 

 

 

 

 

 

Gone concern capital coverage ratio

 

 117.15 

 

 

 

 

 

 

 

1 Includes applicable add-ons of 1.44% for RWA and 0.50% for LRD.    2 A maximum of 25% of the gone concern requirements can be met with instruments that have a remaining maturity of between one and two years. Once at least 75% of the minimum gone concern requirement has been met with instruments that have a remaining maturity of greater than two years, all instruments that have a remaining maturity of between one and two years remain eligible to be included in the total gone concern capital.

 

 

UBS AG standalone regulatory information                                                                                                                                                                   43 


     

Swiss SRB going and gone concern information

USD m, except where indicated

 

31.12.22

 

30.9.22

31.12.21

 

 

 

 

 

 

Eligible going concern capital

 

 

 

 

 

Total going concern capital

 

 65,836 

 

 67,149 

 66,658 

Total tier 1 capital

 

 65,836 

 

 67,149 

 66,658 

Common equity tier 1 capital

 

 53,995 

 

 53,480 

 52,818 

Total loss-absorbing additional tier 1 capital

 

 11,841 

 

 13,669 

 13,840 

of which: high-trigger loss-absorbing additional tier 1 capital

 

 10,654 

 

 12,481 

 11,414 

of which: low-trigger loss-absorbing additional tier 1 capital

 

 1,187 

 

 1,188 

 2,426 

 

 

 

 

 

 

Eligible gone concern capital

 

 

 

 

 

Total gone concern loss-absorbing capacity

 

 46,982 

 

 45,375 

 44,250 

Total tier 2 capital

 

 2,949 

 

 2,949 

 3,129 

of which: low-trigger loss-absorbing tier 2 capital

 

 2,421 

 

 2,426 

 2,594 

of which: non-Basel III-compliant tier 2 capital

 

 528 

 

 523 

 535 

TLAC-eligible senior unsecured debt

 

 44,033 

 

 42,426 

 41,120 

 

 

 

 

 

 

Total loss-absorbing capacity

 

 

 

 

 

Total loss-absorbing capacity

 

 112,818 

 

 112,524 

 110,908 

 

 

 

 

 

 

Denominators for going and gone concern ratios

 

 

 

 

 

Risk-weighted assets phase-in

 

 332,864 

 

 323,364 

 317,913 

of which: investments in Switzerland-domiciled subsidiaries1

 

 39,589 

 

 37,427 

 38,935 

of which: investments in foreign-domiciled subsidiaries1

 

 121,021 

 

 115,512 

 108,982 

Risk-weighted assets fully applied as of 1.1.28

 

 390,128 

 

 377,973 

 382,934 

of which: investments in Switzerland-domiciled subsidiaries1

 

 44,988 

 

 42,530 

 45,273 

of which: investments in foreign-domiciled subsidiaries1

 

 172,887 

 

 165,018 

 167,664 

Leverage ratio denominator

 

 575,461 

 

 553,215 

 593,868 

 

 

 

 

 

 

Capital and loss-absorbing capacity ratios (%)

 

 

 

 

 

Going concern capital ratio, phase-in

 

 19.8 

 

 20.8 

 21.0 

of which: common equity tier 1 capital ratio, phase-in

 

 16.2 

 

 16.5 

 16.6 

Going concern capital ratio, fully applied as of 1.1.28

 

 16.9 

 

 17.8 

 17.4 

of which: common equity tier 1 capital ratio, fully applied as of 1.1.28

 

 13.8 

 

 14.1 

 13.8 

 

 

 

 

 

 

Leverage ratios (%)

 

 

 

 

 

Going concern leverage ratio

 

 11.4 

 

 12.1 

 11.2 

of which: common equity tier 1 leverage ratio

 

 9.4 

 

 9.7 

 8.9 

 

 

 

 

 

 

Capital coverage ratio (%)

 

 

 

 

 

Gone concern capital coverage ratio

 

 117.1 

 

 117.8 

 112.0 

1 Net exposures for direct and indirect investments including holding of regulatory capital instruments in Switzerland-domiciled subsidiaries and for direct and indirect investments including holding of regulatory capital instruments in foreign-domiciled subsidiaries are risk-weighted at 220% and 280%, respectively, for the current year. Risk weights will gradually increase by 5 percentage points per year for Switzerland-domiciled investments and 20 percentage points per year for foreign-domiciled investments until the fully applied risk weights of 250% and 400%, respectively, are applied.

 

Leverage ratio information

Swiss SRB leverage ratio denominator

 

 

 

 

USD bn

 

31.12.22

30.9.22

31.12.21

 

 

 

 

 

Leverage ratio denominator

 

 

 

 

Swiss GAAP total assets

 

 504.8 

 486.1 

 509.9 

Difference between Swiss GAAP and IFRS total assets

 

 156.1 

 196.4 

 125.0 

Less derivatives and SFTs1

 

 (254.7) 

 (310.8) 

 (216.4) 

Less funding provided to significant regulated subsidiaries eligible as gone concern capital

 

 (21.9) 

 (20.8) 

 (21.8) 

On-balance sheet exposures (excluding derivatives and SFTs)

 

 384.3 

 350.9 

 396.7 

Derivatives

 

 88.3 

 101.7 

 89.7 

Securities financing transactions

 

 80.7 

 79.4 

 85.4 

Off-balance sheet items

 

 23.7 

 22.6 

 23.7 

Items deducted from Swiss SRB tier 1 capital

 

 (1.7) 

 (1.4) 

 (1.6) 

Total exposures (leverage ratio denominator)

 

 575.5 

 553.2 

 593.9 

1 The exposures consist of derivative financial instruments, cash collateral receivables on derivative instruments, receivables from SFTs, and margin loans, as well as prime brokerage receivables and financial assets at fair value not held for trading, both related to SFTs. These exposures are presented separately under Derivatives and Securities financing transactions in this table.

p

 

UBS AG standalone regulatory information                                                                                                                                                                   44 


     

Climate risk

Annual | Our climate strategy and governance are determined and overseen at Group level. Similarly, we identify and manage climate risks, including climate-related financial risks, in our own operations, balance sheet, client assets and supply chain on Group level.

In 2022, we made good progress on the execution of our sustainability strategy, and we will continue to advance our own efforts towards the 17 Sustainable Development Goals, recognizing that we, like our clients, have much to learn as we move forward.

Climate-related metrics for the legal entity UBS AG are presented along with respective metrics applicable to UBS Group in the UBS Group AG Annual Report 2022.

    Refer to “Our focus on sustainability and climate” of the “How we create value for our stakeholders” section and to “Sustainability and climate risk” of the “Risk management and control” section of the UBS Group AG Annual Report 2022 for more information

    Refer to “Our sustainability and impact strategy” in the “Strategy” section of the Sustainability Report 2022, available from 10 March 2023 under “Annual reporting” at ubs.com/investors, for more information

 

Non-financial report

UBS Group AG and UBS AG have issued a separate non-financial group report in line with the Global Reporting Initiative (GRI). This report provides disclosures on environmental, social and governance (ESG) matters for UBS as a group. For UBS AG and its consolidated subsidiaries, this report also provides the disclosures on non-financial information required by the German law implementing EU Directive 2014/95 (CSR-Richtlinie-Umsetzungsgesetz  / CSR-RUG), in accordance with Art. 114 of the Securities Trading Act (Wertpapierhandelsgesetz  / WpHG), and for UBS AG on a standalone basis, it provides disclosure under Art. 8 of the EU Taxonomy Regulation. The report is available under “Annual reporting” at ubs.com/investors

    Refer to the Sustainability Report 2022 available at ubs.com/investors, for more information

UBS AG standalone regulatory information                                                                                                                                                                   45 


     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cautionary Statement | This report and the information contained herein are provided solely for information purposes, and are not to be construed as solicitation of an offer to buy or sell any securities or other financial instruments in Switzerland, the United States or any other jurisdiction. No investment decision relating to securities of or relating to UBS Group AG, UBS AG or their affiliates should be made on the basis of this report. Refer to UBS’s most recent Annual Report on Form 20-F, quarterly reports and other information furnished to or filed with the US Securities and Exchange Commission on Form 6-K, available at ubs.com/investors, for additional information.

Rounding | Numbers presented throughout this report may not add up precisely to the totals provided in the tables and text. Percentages and percent changes disclosed in text and tables are calculated on the basis of unrounded figures. Absolute changes between reporting periods disclosed in the text, which can be derived from numbers presented in related tables, are calculated on a rounded basis.

Tables | Within tables, blank fields generally indicate non-applicability or that presentation of any content would not be meaningful, or that information is not available as of the relevant date or for the relevant period. Zero values generally indicate that the respective figure is zero on an actual or rounded basis. Values that are zero on a rounded basis can be either negative or positive on an actual basis.

 

 

 


     

 

UBS Group AG
P.O. Box
CH-8098 Zurich

ubs.com

 

 

 

 

 

 

 


     

Zurich, 06 March 2023

 

 

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in each of the following registration statements of UBS Group AG, UBS AG and their affiliates:

 

(1)      on Form F-3 (Registration Number 333-263376), and each related prospectus currently outstanding under such registration statement,

(2)     on Form S-8 (Registration Numbers 333-200634; 333-200635; 333-200641; 333-200665; 333-215254; 333-215255; 333-228653; and 333-230312; 333-249143), and each related prospectus currently outstanding under any of the aforementioned registration statements,

(3)     the base prospectus of Corporate Asset Backed Corporation (CABCO) dated 23 June 2004 (Registration Number 333-111572),

(4)     the Form 8-K of CABCO dated 23 June 2004 (SEC File Number 001-13444), and

(5)     the Prospectus Supplements relating to the CABCO Series 2004-101 Trust dated 10 May 2004 (Registration Number 033-91744) and 17 May 2004 (Registration Number 033-91744-05),   

 

of our report dated 03 March 2023, with respect to the standalone financial statements of UBS AG for the year ended 31 December 2022 included in this Report of Foreign Private Issuer (Form 6-K) dated 06 March 2023, filed with the Securities and Exchange Commission.

 

 

 

 

 

 

/s/ Ernst & Young Ltd

 

 

 

 

 

 

 

 

 

 

 

 


     

This Form 6-K is hereby incorporated by reference into (1) each of the registration statements of UBS AG on Form F-3 (Registration Number 333-263376), and of UBS Group AG on Form S-8 (Registration Numbers 333-200634; 333-200635; 333-200641; 333-200665; 333-215254; 333-215255; 333-228653; 333-230312; and 333-249143), and into each prospectus outstanding under any of the foregoing registration statements, (2) any outstanding offering circular or similar document issued or authorized by UBS AG that incorporates by reference any Forms 6-K of UBS AG that are incorporated into its registration statements filed with the SEC, and (3) the base prospectus of Corporate Asset Backed Corporation (“CABCO”) dated June 23, 2004 (Registration Number 333-111572), the Form 8-K of CABCO filed and dated June 23, 2004 (SEC File Number 001-13444), and the Prospectus Supplements relating to the CABCO Series 2004-101 Trust dated May 10, 2004 and May 17, 2004 (Registration Number 033-91744 and 033-91744-05). 

 


     

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.

 

 

 

UBS Group AG

 

 

 

By: _/s/ Christopher Castello_______ 

      Name: Christopher Castello

      Title: Group Controller and

            Chief Accounting Officer

 

 

By: _/s/ David Kelly _____________ 

Name:  David Kelly

Title:    Managing Director

 

 

 

UBS AG

 

 

 

By: _/s/ Christopher Castello_______ 

      Name: Christopher Castello

      Title:   Controller and Chief

                 Accounting Officer

 

 

By: _/s/ David Kelly _____________ 

Name:  David Kelly

Title:    Managing Director

 

 

 

 

 

 

Date:  March 6, 2023

 

 

 


UBS (NYSE:UBS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more UBS Charts.
UBS (NYSE:UBS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more UBS Charts.